<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5004846</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1005853</article-id><article-id pub-id-type="publisher-id">PPATHOGENS-D-16-01023</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Cloning</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Cloning</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Protozoans</subject><subj-group><subject>Parasitic Protozoans</subject><subj-group><subject>Entamoeba Histolytica</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene Expression</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogenesis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Parasitology</subject><subj-group><subject>Parasite Groups</subject><subj-group><subject>Apicomplexa</subject><subj-group><subject>Trophozoites</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Protein Domains</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Abscesses</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Abscesses</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzymes</subject><subj-group><subject>Proteases</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Enzymes</subject><subj-group><subject>Proteases</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Overexpression of Differentially Expressed Genes Identified in Non-pathogenic and Pathogenic Entamoeba histolytica Clones Allow Identification of New Pathogenicity Factors Involved in Amoebic Liver Abscess Formation</article-title><alt-title alt-title-type="running-head">Pathogenicity Factors of Entamoeba Histolytica</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Meyer</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Fehling</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Matthiesen</surname><given-names>Jenny</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lorenzen</surname><given-names>Stephan</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schuldt</surname><given-names>Kathrin</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bernin</surname><given-names>Hannah</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zaruba</surname><given-names>Mareen</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lender</surname><given-names>Corinna</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2170-9241</contrib-id><name><surname>Ernst</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ittrich</surname><given-names>Harald</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Roeder</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tannich</surname><given-names>Egbert</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lotter</surname><given-names>Hannelore</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Bruchhaus</surname><given-names>Iris</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Diagnostic and Interventional Radiology Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Zoological Institute, Molecular Physiology, Christian-Albrechts University Kiel, Kiel, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Johnson</surname><given-names>Patricia J.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of California Los Angeles, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> HL IB.</p></list-item><list-item><p><bold>Data curation:</bold> SL HF IB.</p></list-item><list-item><p><bold>Formal analysis:</bold> HF SL KS IB.</p></list-item><list-item><p><bold>Funding acquisition:</bold> IB HL MM.</p></list-item><list-item><p><bold>Investigation:</bold> MM HF JM HB MZ CL TE.</p></list-item><list-item><p><bold>Methodology:</bold> MM HF JM ET HL IB.</p></list-item><list-item><p><bold>Project administration:</bold> HL IB.</p></list-item><list-item><p><bold>Software:</bold> SL KS.</p></list-item><list-item><p><bold>Supervision:</bold> ET HL IB.</p></list-item><list-item><p><bold>Validation:</bold> MM HF JM HB MZ CL TE HI HL IB.</p></list-item><list-item><p><bold>Visualization:</bold> MM HF JM MZ CL IB HL.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> TR ET HL IB.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> TR HI ET HL IB.</p></list-item></list></p></fn><corresp id="cor001">* E-mail: <email>lotter@bnitm.de</email> (HL); <email>bruchhaus@bnitm.de</email> (IB)</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2016</year></pub-date><volume>12</volume><issue>8</issue><elocation-id>e1005853</elocation-id><history><date date-type="received"><day>10</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>9</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Meyer et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Meyer et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="ppat.1005853.pdf"/><abstract><p>We here compared pathogenic (p) and non-pathogenic (np) isolates of <italic>Entamoeba histolytica</italic> to identify molecules involved in the ability of this parasite to induce amoebic liver abscess (ALA)-like lesions in two rodent models for the disease. We performed a comprehensive analysis of 12 clones (A1&#x02013;A12) derived from a non-pathogenic isolate HM-1:IMSS-A and 12 clones (B1&#x02013;B12) derived from a pathogenic isolate HM-1:IMSS-B. &#x0201c;Non-pathogenicity&#x0201d; included the induction of small and quickly resolved lesions while &#x0201c;pathogenicity&#x0201d; comprised larger abscess development that overstayed day 7 post infection. All A-clones were designated as non-pathogenic, whereas 4 out of 12 B-clones lost their ability to induce ALAs in gerbils. No correlation between ALA formation and cysteine peptidase (CP) activity, haemolytic activity, erythrophagocytosis, motility or cytopathic activity was found. To identify the molecular framework underlying different pathogenic phenotypes, three clones were selected for in-depth transcriptome analyses. Comparison of a non-pathogenic clone A1<sup>np</sup> with pathogenic clone B2<sup>p</sup> revealed 76 differentially expressed genes, whereas comparison of a non-pathogenic clone B8<sup>np</sup> with B2<sup>p</sup> revealed only 19 differentially expressed genes. Only six genes were found to be similarly regulated in the two non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup> in comparison with the pathogenic clone B2<sup>p</sup>. Based on these analyses, we chose 20 candidate genes and evaluated their roles in ALA formation using the respective gene-overexpressing transfectants. We conclude that different mechanisms lead to loss of pathogenicity. In total, we identified eight proteins, comprising a metallopeptidase, C2 domain proteins, alcohol dehydrogenases and hypothetical proteins, that affect the pathogenicity of <italic>E</italic>. <italic>histolytica</italic>.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>The pathogen <italic>Entamoeba histolytica</italic> can live asymptomatically in the human gut, or it can disrupt the intestinal barrier and induce life-threatening abscesses in different organs, most often in the liver. The molecular framework that enables this invasive, highly pathogenic phenotype is still not well understood. In order to identify factors that are positively or negatively correlated for invasion and destruction of the liver, we used a unique tool, <italic>E</italic>. <italic>histolytica</italic> clones that differ dramatically in their pathogenicity, while sharing almost identical genetic background. Based on comprehensive transcriptome studies of these clones, we identified a set of candidate genes that are potentially involved in pathogenicity. Using ectopic overexpression of the most promising candidates, either in pathogenic or in non-pathogenic <italic>Entamoeba</italic> clones, we identified genes where high expression reduced pathogenicity and only one gene that increased pathogenicity to a certain extend.</p><p>Taken together, the current study identifies novel pathogenicity factors of <italic>E</italic>. <italic>histolytica</italic> and highlights the observation that various different genes contribute to pathogenicity.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Deutsche Forschungsgemeinschaft (DE)</institution></funding-source><award-id>Br1744/11-2</award-id><principal-award-recipient><name><surname>Bruchhaus</surname><given-names>Iris</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution>J&#x000fc;rgen Manchot Stiftung</institution></funding-source><principal-award-recipient><name><surname>Meyer</surname><given-names>Martin</given-names></name></principal-award-recipient></award-group><funding-statement>The work was funded by the Deutsche Forschungsgemeinschaft (DFG, Br1744/11-2) and J&#x000fc;rgen Manchot Stiftung. The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="6"/><page-count count="27"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The protozoan parasite <italic>Entamoeba histolytica</italic> is responsible for approximately 50 million cases of invasive amoebiasis per year, resulting in an annual death toll of 40,000&#x02013;100,000 [<xref rid="ppat.1005853.ref001" ref-type="bibr">1</xref>]. The parasite life cycle is relatively simple, comprising infectious cysts that can survive outside the host and vegetative trophozoites that proliferate in the human gut. After infection, <italic>E</italic>. <italic>histolytica</italic> trophozoites can asymptomatically persist for months or years in its human host [<xref rid="ppat.1005853.ref002" ref-type="bibr">2</xref>].</p><p>Under as yet unknown circumstances, <italic>E</italic>. <italic>histolytica</italic> escapes from the gut lumen, either by penetrating the intestinal mucosa and inducing colitis, or by disseminating to other organs, most commonly the liver, where it induces abscess formation. The factors that determine the clinical outcomes of <italic>E</italic>. <italic>histolytica</italic> infections are not well understood. Possible factors comprise genetic make-up of the parasite and/or host, the immune response mounted by the host, concomitant infections and host diet. Identification of <italic>E</italic>. <italic>histolytica</italic> pathogenicity factors is a major topic in the field. Recently, research dealing with <italic>E</italic>. <italic>histolytica</italic> pathogenicity factors has mainly focused on a triad of protein families, namely, galactose/N-acetyl <sc>d</sc>-galactosamine&#x02013;inhibitable Gal/GalNAc-lectins, cysteine peptidases (CPs) and amoebapores. Results obtained using transgenic amoebae supported the hypothesis that these molecules are involved in amoebic liver abscess (ALA) formation [<xref rid="ppat.1005853.ref003" ref-type="bibr">3</xref>&#x02013;<xref rid="ppat.1005853.ref006" ref-type="bibr">6</xref>]. Nevertheless, homologues of the majority of these potential pathogenicity factors are also present in the non-pathogenic sister species <italic>Entamoeba dispar</italic>, a commensal protozoan that is genetically closely related to <italic>E</italic>. <italic>histolytica</italic>. Therefore, it remains to be shown whether one of these factors or their combination is responsible for amoeba pathogenicity or whether additional factors are involved. Thus, the mechanisms and processes enabling <italic>E</italic>. <italic>histolytica</italic> to penetrate host tissues and induce colitis and/or liver abscesses are still not understood. One straight-forward approach of identifying pathogenicity factors is a direct comparison of pathogenic and non-pathogenic <italic>E</italic>. <italic>histolytica</italic> isolates that has been performed using comparative microarray and proteome approaches [<xref rid="ppat.1005853.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="ppat.1005853.ref010" ref-type="bibr">10</xref>]. Unfortunately, these studies used two isolates with completely different genetic backgrounds (pathogenic isolate HM-1:IMSS and non-pathogenic isolate Rahman). This rendered the straight-forward identification of pathogenicity factors almost impossible. In addition, an in-depth phenotypical characterisation of the Rahman isolate revealed a number of genomic defects that presumably interfere with its virulence capacity [<xref rid="ppat.1005853.ref010" ref-type="bibr">10</xref>].</p><p>Recently, we identified two cell lines that were both derived from the clinical <italic>E</italic>. <italic>histolytica</italic> isolate HM-1:IMSS but which significantly differ in their pathogenicity. Whereas cell line HM-1:IMSS-A completely lost its ability to induce ALAs in gerbils (<italic>Meriones unguiculatus</italic>) and mice (<italic>Mus musculus</italic>), cell line HM-1:IMSS-B is highly aggressive and induces large ALAs. Comparative transcriptomic and proteomic studies of these cell lines have already been performed [<xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>]. The studies revealed 31 differentially (&#x02265;3-fold) expressed genes [<xref rid="ppat.1005853.ref012" ref-type="bibr">12</xref>] and 31 proteins with differential abundances in HM-1:IMSS-A and HM-1:IMSS-B [<xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>]. However, an overlap of only two molecules was found between the proteomic and transcriptomic approaches.</p><p>Until now, neither pathogenic nor non-pathogenic cell lines have been cloned, and therefore it is possible that they consist of a mixture of cells. Thus, in the present study, both cell lines were cloned to obtain homogenous cell populations, allowing analyses of the pathogenicity factors in a straight-forward fashion. Twelve clones derived from the non-pathogenic cell line HM-1:IMSS-A (A1&#x02013;A12) and 12 clones derived from the pathogenic cell line HM-1:IMSS-B (B1&#x02013;B12) were generated. All 24 clones were analysed for their ability to induce ALAs in gerbils and for their specific CP activity. One non-pathogenic A-clone (A1<sup>np</sup>), one pathogenic B-clone (B2<sup>p</sup>) and one non-pathogenic B-clone (B8<sup>np</sup>) were analysed in more detail, including their time course of ALA formation, growth, size, motility, haemolytic activity, erythrophagocytosis, cytopathic activity and transcriptome profiles. Furthermore, transfectants overexpressing genes that were identified as differentially expressed between the pathogenic and non-pathogenic clones were tested for their involvement in ALA formation.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec003"><title>Generation of <italic>E</italic>. <italic>histolytica</italic> clones and pathogenicity determinations</title><p>To analyse whether the <italic>E</italic>. <italic>histolytica</italic> cell lines consisted of a mixture of different cell types with different pathogenic phenotypes, the cell lines were cloned by limited dilution method. This resulted in 12 clones derived from cell line HM-1:IMSS-A and 12 clones derived from cell line HM-1:IMSS-B. The ALAs-generating ability of the different clones was analysed using the gerbil model. The animals were sacrificed 7 days post infection, and ALA sizes were determined. The results clearly indicated that the HM-1:IMSS-A cell line consists of a homogenous cell population. Except a few cases of small ALA formation, the majority of animals infected with different A-clones showed no ALA formation (<xref ref-type="fig" rid="ppat.1005853.g001">Fig 1</xref>). The results were more divergent for clones derived from the HM-1:IMSS-B cell line. Eight clones, B2&#x02013;B7, B9 and B10, showed a pathogenic phenotype comparable with the original cell line HM-1:IMSS-B. However, although clones B1, B8, B11 and B12 were derived from the pathogenic cell line, their ability to induce abscess formation was significantly reduced. This was especially evident for clone B8 that did not induce any abscess formation 7 days post infection (<xref ref-type="fig" rid="ppat.1005853.g001">Fig 1</xref>).</p><fig id="ppat.1005853.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.g001</object-id><label>Fig 1</label><caption><title>Analysis of ALA formation after infecting gerbils with various <italic>E</italic>. <italic>histolytica</italic> clones.</title><p>Cell lines HM-1:IMSS-A and HM-1:IMSS-B were cloned by a limited dilution method, resulting in 12 clones derived from HM-1:IMSS-A (A1&#x02013;A12) and 12 clones derived from HM-1:IMSS-B (B1&#x02013;B12). Gerbils were infected with 1 &#x000d7; 10<sup>6</sup> trophozoites of the different cell lines and clones. Seven days post infection, liver abscess formation was analysed and area of ALA (mm<sup>2</sup>) was determined. Significance (<italic>p</italic>-values) was established by the Mann-Whitney <italic>U</italic> test. <italic>p</italic>-values were calculated relative to control (HM-1:IMSS-A or HM-1:IMSS-B, respectively). *<italic>p</italic> = 0.0286, **<italic>p</italic> = 0.079. For detailed information see <xref ref-type="supplementary-material" rid="ppat.1005853.s001">S1 Table</xref>.</p></caption><graphic xlink:href="ppat.1005853.g001"/></fig><p>The non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup> and pathogenic clone B2<sup>p</sup> have been continuously cultivated for more than 5 years, without any change of the respective phenotypes. The pathogenic phenotype of clone B2<sup>p</sup> remained especially stable over the years without the need for animal passaging.</p><p>To ensure that the observed phenotypes were indeed stable and uniform, the non-pathogenic clone B8<sup>np</sup> and the highly pathogenic clone B2<sup>p</sup> were sub-cloned. All sub-clones showed the same phenotype as the respective mother clone. All five sub-clones derived from the non-pathogenic clone B8<sup>np</sup> were unable to induce ALAs, whereas all five sub-clones of the pathogenic clone B2<sup>p</sup> produced large abscesses (<xref ref-type="fig" rid="ppat.1005853.g002">Fig 2</xref>).</p><fig id="ppat.1005853.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.g002</object-id><label>Fig 2</label><caption><title>Analysis of ALA formation after infecting gerbils with various sub-clones derived from clone B8<sup>np</sup> and clone B2<sup>p</sup>.</title><p>Clones B8<sup>np</sup> and B2<sup>p</sup> were sub-cloned by a limited dilution method, resulting in five sub-clones each (B8_1&#x02013;5 and B2_1&#x02013;5, respectively). Gerbils were infected with 1 &#x000d7; 10<sup>6</sup> trophozoites of the various sub-clones. Seven days post infection, liver abscess formation was analysed, and area of ALA (mm<sup>2</sup>) was determined. Significance (<italic>p</italic>-values) was established by the Mann-Whitney <italic>U</italic> test. <italic>p</italic>-values were calculated relative to control (clone B8<sup>np</sup> or clone B2<sup>p</sup>, respectively). For detailed information see <xref ref-type="supplementary-material" rid="ppat.1005853.s001">S1 Table</xref>.</p></caption><graphic xlink:href="ppat.1005853.g002"/></fig></sec><sec id="sec004"><title>Determination of cysteine peptidase activity</title><p>Recently, it was shown that CP activity of the pathogenic cell line HM-1:IMSS-B is approximately ten times greater (110 &#x000b1; 25 mU/mg) than in the non-pathogenic cell line HM-1:IMSS-A (15 &#x000b1; 5 mU/mg) [<xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>]. A similar difference has been measured for the non-pathogenic clone A1<sup>np</sup> (15 &#x000b1; 10 mU/mg) and the pathogenic clone B2<sup>p</sup> (123 &#x000b1; 60 mU/mg) [<xref rid="ppat.1005853.ref003" ref-type="bibr">3</xref>]. To investigate if the observed correlation between CP activity and pathogenicity is generally valid, the activities of all A- and B-clones were determined and correlated with ALA formation (<xref ref-type="fig" rid="ppat.1005853.g003">Fig 3A</xref>). In general, the clones derived from HM-1:IMSS-B had a significantly higher CP activity (85 &#x000b1; 50 mU/mg) than clones derived from HM-1:IMSS-A (18 &#x000b1; 11; <italic>p</italic> &#x0003c; 0.0001). However, a direct correlation between the CP activity and ALA formation was not observed. This was obvious especially for clones B1 and B12. Although these clones have a high CP activity (198 &#x000b1; 52 mU/mg and 139 &#x000b1; 89 mU/mg, respectively), they only induce small ALAs (Figs <xref ref-type="fig" rid="ppat.1005853.g002">2</xref> and <xref ref-type="fig" rid="ppat.1005853.g003">3A</xref>). CPs EhCP-A1, EhCP-A2, EhCP-A4, EhCP-A5 and EhCP-A7 can be visualised by substrate gel electrophoresis [<xref rid="ppat.1005853.ref003" ref-type="bibr">3</xref>]. Here, the results from substrate gel experiments clearly indicated that different CP activities of the various A- and B-clones are not linked to the expression of a single peptidase (<xref ref-type="fig" rid="ppat.1005853.g003">Fig 3B</xref>).</p><fig id="ppat.1005853.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.g003</object-id><label>Fig 3</label><caption><title>Determination of cysteine peptidase activity.</title><p>(A) CP activities of cell line HM-1:IMSS-A, clones A1&#x02013;A12, cell line HM-1:IMSS-B and clones B1&#x02013;B12 were measured at least four times in duplicate. (B) Substrate gel electrophoresis of clones A1&#x02013;A12 and clones B1&#x02013;B12. Cell lysates were separated on SDS-PAGE co-polymerised with gelatine. To visualise CP activity of proteins, gels were stained with Coomassie blue and the images were inverted. Standards are indicated on the left (kDa). Significance (<italic>p-</italic>values) was established using an unpaired t test. <italic>p</italic>-values were calculated relative to control (HM-1:IMSS-A or HM-1:IMSS-B, respectively). *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.005, ***<italic>p</italic> &#x0003c; 0.001, ns: not significant. For detailed information see <xref ref-type="supplementary-material" rid="ppat.1005853.s001">S1 Table</xref>.</p></caption><graphic xlink:href="ppat.1005853.g003"/></fig></sec><sec id="sec005"><title>Abscess formation over time</title><p>To identify the underlying mechanisms of different virulence phenotypes, three clones were selected for in-depth analyses. These were as follows: a non-pathogenic clone derived from HM-1:IMSS-A (clone A1<sup>np</sup>), pathogenic clone B2<sup>p</sup> that induced the largest ALAs among the B-clones, and clone B8<sup>np</sup> that completely lost its ability to produce ALAs. Both B-clones have been derived from HM-1:IMSS-B.</p><p>Magnetic resonance imaging (MRI) was employed to follow post-infection abscess formation over time in more detail. Infection time course was analysed over 10 days in gerbil and mouse ALA models using the three clones, A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup> (<xref ref-type="fig" rid="ppat.1005853.g004">Fig 4A and 4B</xref>). Our findings clearly confirmed the results of animal experiments described above (<xref ref-type="fig" rid="ppat.1005853.g001">Fig 1</xref>). On day 7 post infection, no or very small ALAs were detected in both animal models with the two non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup>, whereas unequivocal abscess formation was observed with clone B2<sup>p</sup> (<xref ref-type="fig" rid="ppat.1005853.g004">Fig 4A and 4B</xref>). Nevertheless, it became apparent that clone A1<sup>np</sup> was also able to induce abscess formation initially, as lesions were detected on day 3 post infection. However, these ALAs were smaller compared with ALAs seen during clone B2<sup>p</sup> infection and were more rapidly resolved. In contrast to clone A1<sup>np</sup>, the pathogenicity of clone B8<sup>np</sup> was almost completely abolished. No ALAs were detected in gerbils infected with this clone, while, in mice, ALAs on day 3 post infection were significantly smaller compared with ALAs induced by clone B2<sup>p</sup> (<xref ref-type="fig" rid="ppat.1005853.g004">Fig 4A and 4B</xref>).</p><fig id="ppat.1005853.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.g004</object-id><label>Fig 4</label><caption><title>Analysis of the time course of ALA formation after infecting gerbils (A) and mice (B) with clones A1<sup>np</sup>, B2<sup>p</sup> or B8<sup>np</sup>.</title><p>Gerbils were infected with 1 &#x000d7; 10<sup>6</sup> trophozoites, and mice were infected with 2.5 &#x000d7; 10<sup>5</sup> trophozoites. Abscess sizes were determined on days 3, 5, 7 and 10 post infection using magnetic resonance imaging (MRI). Abscesses are shown in red circles. Significance was established using an unpaired t test. <italic>p</italic>-values were calculated relative to control (clone B2<sup>p</sup>). *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.005, ***<italic>p</italic> &#x0003c; 0.001, <italic>****p</italic> &#x0003c; 0.0001. For detailed information see <xref ref-type="supplementary-material" rid="ppat.1005853.s001">S1 Table</xref>.</p></caption><graphic xlink:href="ppat.1005853.g004"/></fig></sec><sec id="sec006"><title>Phenotypical characterisation of clones A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup></title><p>Clones A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup> were then phenotypically characterised. This included determination of size, growth rate, haemolytic activity, erythrophagocytosis and cytopathic activity.</p><p>Microscopic analyses indicated that trophozoite sizes of clone B2<sup>p</sup> (818 &#x000b1; 235 &#x003bc;m<sup>2</sup>) and clone B8<sup>np</sup> (782 &#x000b1; 193 &#x003bc;m<sup>2</sup>) differed significantly and were larger in comparison with cells from clone A1<sup>np</sup> (591 &#x000b1; 154 &#x003bc;M<sup>2</sup>) (<xref ref-type="table" rid="ppat.1005853.t001">Table 1</xref>).</p><table-wrap id="ppat.1005853.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.t001</object-id><label>Table 1</label><caption><title>Phenotypical characterisation of clones A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup>.</title></caption><alternatives><graphic id="ppat.1005853.t001g" xlink:href="ppat.1005853.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Phenotype</th><th align="center" rowspan="1" colspan="1">Clone A1<sup>np</sup></th><th align="center" rowspan="1" colspan="1">Clone B2<sup>p</sup></th><th align="center" rowspan="1" colspan="1">Clone B8<sup>np</sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Abscess area (mm<sup>2</sup>)<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">89 &#x000b1; 52</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Cysteine peptidase activity (mU/mg)<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">15 &#x000b1; 9.5</td><td align="center" rowspan="1" colspan="1">123 &#x000b1; 69</td><td align="center" rowspan="1" colspan="1">38 &#x000b1; 25</td></tr><tr><td align="left" rowspan="1" colspan="1">Size (&#x003bc;M<sup>2</sup>)<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">591 &#x000b1; 154</td><td align="center" rowspan="1" colspan="1">818 &#x000b1; 235</td><td align="center" rowspan="1" colspan="1">782 &#x000b1; 193</td></tr><tr><td align="left" rowspan="1" colspan="1">Growth rate (doubling time, h)<xref ref-type="table-fn" rid="t001fn004"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">12.02 &#x000b1; 2.77</td><td align="center" rowspan="1" colspan="1">7.96 &#x000b1; 1.63</td><td align="center" rowspan="1" colspan="1">9.49 &#x000b1; 2.22</td></tr><tr><td align="left" rowspan="1" colspan="1">Haemolytic activity (%)<xref ref-type="table-fn" rid="t001fn005"><sup>e</sup></xref></td><td align="center" rowspan="1" colspan="1">6.85 &#x000b1; 1.34</td><td align="center" rowspan="1" colspan="1">4.54 &#x000b1; 0.63</td><td align="center" rowspan="1" colspan="1">0.79 &#x000b1; 0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Erythrophagocytosis (OD<sub>397nm</sub>)<xref ref-type="table-fn" rid="t001fn006"><sup>f</sup></xref></td><td align="center" rowspan="1" colspan="1">1.1 &#x000b1; 0.29</td><td align="center" rowspan="1" colspan="1">0.64 &#x000b1; 0.17</td><td align="center" rowspan="1" colspan="1">1.59 &#x000b1; 0.25</td></tr><tr><td align="left" rowspan="1" colspan="1">Cytopathic activity (percentage of monolyer disruption)<xref ref-type="table-fn" rid="t001fn007"><sup>g</sup></xref></td><td align="center" rowspan="1" colspan="1">53 &#x000b1; 18</td><td align="center" rowspan="1" colspan="1">17 &#x000b1; 29</td><td align="center" rowspan="1" colspan="1">0 &#x000b1; 13</td></tr><tr><td align="left" rowspan="1" colspan="1">Motility (accumulated distance, &#x003bc;M/10 min)<xref ref-type="table-fn" rid="t001fn008"><sup>h</sup></xref></td><td align="center" rowspan="1" colspan="1">228&#x000b1;157</td><td align="center" rowspan="1" colspan="1">378&#x000b1;172</td><td align="center" rowspan="1" colspan="1">453&#x000b1;184</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>a</sup>Abscess area was analysed in the gerbil model 7 days post infection; n = 5&#x02013;14; A1<sup>np</sup>/B2<sup>p</sup> ****<italic>p</italic> &#x0003c; 0.0001; B2<sup>p</sup>/B8<sup>np</sup> ***<italic>p</italic> = 0.0008</p></fn><fn id="t001fn002"><p><sup>b</sup>n = 9&#x02013;12; A1<sup>np</sup>/B2<sup>p</sup> ****<italic>p</italic> &#x0003c; 0.0001; B2<sup>p</sup>/B8<sup>np</sup>; ***<italic>p</italic> = 0.0003; A1<sup>np</sup>/B8<sup>np</sup> **<italic>p</italic> = 0.0093</p></fn><fn id="t001fn003"><p><sup>c</sup>n = 80; A1<sup>np</sup>/B2<sup>p</sup>, A1<sup>np</sup>/B8<sup>np</sup> ****<italic>p</italic> &#x0003c; 0.0001</p></fn><fn id="t001fn004"><p><sup>d</sup>n = 10&#x02013;15; A1<sup>np</sup>/B2<sup>p</sup> ****<italic>p</italic> &#x0003c; 0.0001; A1<sup>np</sup>/B8<sup>np</sup> *<italic>p</italic> = 0.0167</p></fn><fn id="t001fn005"><p><sup>e</sup>n = 5&#x02013;6; A1<sup>np</sup>/B2<sup>p</sup>, A1<sup>np</sup>/B8<sup>np</sup>, B2<sup>p</sup>/B8<sup>np</sup> **<italic>p</italic> &#x0003c; 0.0043</p></fn><fn id="t001fn006"><p><sup>f</sup>n = 8&#x02013;12; A1<sup>np</sup>/B2<sup>p</sup>, B2<sup>p</sup>/B8<sup>np</sup> ****<italic>p</italic> &#x0003c; 0.0001; A1<sup>np</sup>/B8<sup>np</sup> *<italic>p</italic> = 0.011</p></fn><fn id="t001fn007"><p><sup>g</sup>n = 18; A1<sup>np</sup>/B2<sup>p</sup>, A1<sup>np</sup>/B8<sup>np</sup> ****<italic>p</italic> &#x0003c; 0.0001; B2<sup>p</sup>/B8<sup>np</sup> *<italic>p</italic> = 0.0266</p></fn><fn id="t001fn008"><p><sup>h</sup>n = 80; A1<sup>np</sup>/B2<sup>p</sup>, A1<sup>np</sup>/B8<sup>np</sup> ****<italic>p</italic> &#x0003c; 0.0001, B2<sup>p</sup>/B8<sup>np</sup> **<italic>p</italic> = 0.0013</p></fn></table-wrap-foot></table-wrap><p>Clone A1<sup>np</sup> grew significantly slower in comparison with clone B2<sup>p</sup> and clone B8<sup>np</sup>. The doubling time of clone A1<sup>np</sup> was approximately 12 &#x000b1; 2.7 h, whereas it was approximately 8 &#x000b1; 1.6 h for clone B2<sup>p</sup> and 9.5 &#x000b1; 2.2 h for clone B8<sup>np</sup> (<xref ref-type="table" rid="ppat.1005853.t001">Table 1</xref>).</p><p>With an accumulated distance of 228 (&#x000b1;156) &#x003bc;m/10 min the amoebae of clone A1<sup>np</sup> move significantly slower in comparison to amoebae of clone B2<sup>p</sup> and clone B8<sup>np</sup> (376 &#x000b1;172 &#x003bc;m/10 min (<italic>p</italic> &#x0003c; 0.0001) and 453 &#x000b1;184 &#x003bc;m/10 min (<italic>p</italic> &#x0003c; 0.0001), respectively). While clone B8<sup>np</sup> moved significantly faster than B2<sup>p</sup> (<italic>p</italic> &#x0003c; 0.0013) (<xref ref-type="table" rid="ppat.1005853.t001">Table 1</xref>).</p><p>Clone A1<sup>np</sup> and clone B2<sup>p</sup> were able to lyse erythrocytes, but no haemolytic activity was detected for clone B8<sup>np</sup>. In addition, no correlation of haemolytic activity with pathogenicity was observed, since the non-pathogenic clone A1<sup>np</sup> had the highest activity (<xref ref-type="table" rid="ppat.1005853.t001">Table 1</xref>). By contrast, clone B8<sup>np</sup> displayed the highest erythrophagocytosis rate, followed by clone A1<sup>np</sup> and clone B2<sup>p</sup>.</p><p>Cytopathic activity (percentage of monolayer disruption) was highest for clone A1<sup>np</sup> followed by clone B2<sup>p</sup>. Clone B8<sup>np</sup> was unable to disrupt a cell monolayer (<xref ref-type="table" rid="ppat.1005853.t001">Table 1</xref>).</p></sec><sec id="sec007"><title>Transcriptome comparisons of clones A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup></title><p>RNAseq experiments were performed to identify differences in gene expression profiles of clones A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup>. Comparison of the non-pathogenic clone A1<sup>np</sup> and pathogenic clone B2<sup>p</sup> revealed 76 differentially expressed genes (threshold &#x02265; 3-fold, <italic>p</italic>-value adjusted (padj) &#x0003c; 0.05). Some genes (46) were expressed more highly in clone A1<sup>np</sup> and some (30) in clone B2<sup>p</sup> (Tables <xref ref-type="table" rid="ppat.1005853.t002">2</xref> and <xref ref-type="table" rid="ppat.1005853.t003">3</xref>, <xref ref-type="supplementary-material" rid="ppat.1005853.s002">S2 Table</xref>). From the 46 genes with higher expression levels in clone A1<sup>np</sup> 10 code for surface proteins (EHI_015290, EHI_082070, EHI_118130, EHI_169280, EHI_074080, EHI_075660 EHI_164900, EHI_039020, EHI_006170, EHI_086540) [<xref rid="ppat.1005853.ref013" ref-type="bibr">13</xref>]. Amongst them are 2 members of the C2 domain protein family and 2 members of the Rab family. Since the analysis of the surface proteome referred to was performed with trophozoites of cell line A, it was not surprising that genes with higher expression levels in clone B2<sup>p</sup> could not be identified as surface associated [<xref rid="ppat.1005853.ref013" ref-type="bibr">13</xref>].</p><table-wrap id="ppat.1005853.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.t002</object-id><label>Table 2</label><caption><title>Genes differentially more highly expressed in clone A1<sup>np</sup> than in clone B2<sup>p</sup> (threshold &#x02265; 3.0, padj &#x02264; 0.05).</title></caption><alternatives><graphic id="ppat.1005853.t002g" xlink:href="ppat.1005853.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">SN</th><th align="center" rowspan="1" colspan="1">Gene ID</th><th align="center" colspan="2" rowspan="1">Expression level</th><th align="center" rowspan="1" colspan="1">Fold change</th><th align="center" rowspan="1" colspan="1">padj</th><th align="left" rowspan="1" colspan="1">Product</th></tr><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Clone A1<sup>np</sup></th><th align="center" rowspan="1" colspan="1">Clone B2<sup>p</sup></th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">EHI_015290</td><td align="char" char="." rowspan="1" colspan="1">5475.48</td><td align="char" char="." rowspan="1" colspan="1">24.50</td><td align="char" char="." rowspan="1" colspan="1">223.47</td><td align="right" rowspan="1" colspan="1">7.95E-52</td><td align="left" rowspan="1" colspan="1">C2 domain protein (EhC2-3)</td></tr><tr><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">EHI_042870</td><td align="char" char="." rowspan="1" colspan="1">1097.95</td><td align="char" char="." rowspan="1" colspan="1">7.36</td><td align="char" char="." rowspan="1" colspan="1">149.12</td><td align="right" rowspan="1" colspan="1">1.15E-36</td><td align="left" rowspan="1" colspan="1">cell surface protease gp63 (EhMP8-2)</td></tr><tr><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">EHI_082070</td><td align="char" char="." rowspan="1" colspan="1">732.36</td><td align="char" char="." rowspan="1" colspan="1">7.75</td><td align="char" char="." rowspan="1" colspan="1">94.48</td><td align="right" rowspan="1" colspan="1">9.72E-32</td><td align="left" rowspan="1" colspan="1">Rab family GTPase (EhRab7D)</td></tr><tr><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">EHI_059860</td><td align="char" char="." rowspan="1" colspan="1">884.90</td><td align="char" char="." rowspan="1" colspan="1">11.47</td><td align="char" char="." rowspan="1" colspan="1">77.14</td><td align="right" rowspan="1" colspan="1">1.95E-32</td><td align="left" rowspan="1" colspan="1">C2 domain-containing protein (EhC2-5)</td></tr><tr><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">EHI_118130</td><td align="char" char="." rowspan="1" colspan="1">1213.30</td><td align="char" char="." rowspan="1" colspan="1">20.11</td><td align="char" char="." rowspan="1" colspan="1">60.31</td><td align="right" rowspan="1" colspan="1">1.96E-26</td><td align="left" rowspan="1" colspan="1">C2 domain-containing protein (EhC2-2)</td></tr><tr><td align="right" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">EHI_169280</td><td align="char" char="." rowspan="1" colspan="1">287.26</td><td align="char" char="." rowspan="1" colspan="1">5.67</td><td align="char" char="." rowspan="1" colspan="1">50.61</td><td align="right" rowspan="1" colspan="1">2.47E-21</td><td align="left" rowspan="1" colspan="1">Rab family GTPase (EhRab7E)</td></tr><tr><td align="right" rowspan="1" colspan="1">7</td><td align="right" rowspan="1" colspan="1">EHI_074080</td><td align="char" char="." rowspan="1" colspan="1">281.71</td><td align="char" char="." rowspan="1" colspan="1">8.54</td><td align="char" char="." rowspan="1" colspan="1">32.95</td><td align="right" rowspan="1" colspan="1">4.72E-14</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">8</td><td align="right" rowspan="1" colspan="1">EHI_187090</td><td align="char" char="." rowspan="1" colspan="1">197.41</td><td align="char" char="." rowspan="1" colspan="1">7.75</td><td align="char" char="." rowspan="1" colspan="1">25.44</td><td align="right" rowspan="1" colspan="1">5.05E-14</td><td align="left" rowspan="1" colspan="1">Rab family GTPase (EhRab7G)</td></tr><tr><td align="right" rowspan="1" colspan="1">9</td><td align="right" rowspan="1" colspan="1">EHI_155060</td><td align="char" char="." rowspan="1" colspan="1">20.53</td><td align="char" char="." rowspan="1" colspan="1">2.76</td><td align="char" char="." rowspan="1" colspan="1">7.42</td><td align="right" rowspan="1" colspan="1">0.0339</td><td align="left" rowspan="1" colspan="1">chaperone ClpB</td></tr><tr><td align="right" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">EHI_005657</td><td align="char" char="." rowspan="1" colspan="1">71.28</td><td align="char" char="." rowspan="1" colspan="1">10.09</td><td align="char" char="." rowspan="1" colspan="1">7.06</td><td align="right" rowspan="1" colspan="1">0.0012</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">11</td><td align="right" rowspan="1" colspan="1">EHI_151890</td><td align="char" char="." rowspan="1" colspan="1">110.74</td><td align="char" char="." rowspan="1" colspan="1">17.13</td><td align="char" char="." rowspan="1" colspan="1">6.46</td><td align="right" rowspan="1" colspan="1">1.85E-05</td><td align="left" rowspan="1" colspan="1">EF-hand calcium-binding domain-containing protein</td></tr><tr><td align="right" rowspan="1" colspan="1">12</td><td align="right" rowspan="1" colspan="1">EHI_026360</td><td align="char" char="." rowspan="1" colspan="1">1270.94</td><td align="char" char="." rowspan="1" colspan="1">215.46</td><td align="char" char="." rowspan="1" colspan="1">5.89</td><td align="right" rowspan="1" colspan="1">5.81E-05</td><td align="left" rowspan="1" colspan="1">phosphoserine aminotransferase (EhPSAT)</td></tr><tr><td align="right" rowspan="1" colspan="1">13</td><td align="right" rowspan="1" colspan="1">EHI_075660</td><td align="char" char="." rowspan="1" colspan="1">297.80</td><td align="char" char="." rowspan="1" colspan="1">50.93</td><td align="char" char="." rowspan="1" colspan="1">5.84</td><td align="right" rowspan="1" colspan="1">1.40E-05</td><td align="left" rowspan="1" colspan="1">CAAX prenyl protease (EhCAAX)</td></tr><tr><td align="right" rowspan="1" colspan="1">14</td><td align="right" rowspan="1" colspan="1">EHI_097480</td><td align="char" char="." rowspan="1" colspan="1">483.02</td><td align="char" char="." rowspan="1" colspan="1">84.95</td><td align="char" char="." rowspan="1" colspan="1">5.68</td><td align="right" rowspan="1" colspan="1">2.33E-05</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">15</td><td align="right" rowspan="1" colspan="1">EHI_075690</td><td align="char" char="." rowspan="1" colspan="1">986.11</td><td align="char" char="." rowspan="1" colspan="1">178.99</td><td align="char" char="." rowspan="1" colspan="1">5.50</td><td align="right" rowspan="1" colspan="1">3.82E-07</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">16</td><td align="right" rowspan="1" colspan="1">EHI_137080</td><td align="char" char="." rowspan="1" colspan="1">2264.50</td><td align="char" char="." rowspan="1" colspan="1">437.89</td><td align="char" char="." rowspan="1" colspan="1">5.17</td><td align="right" rowspan="1" colspan="1">2.32E-05</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">17</td><td align="right" rowspan="1" colspan="1">EHI_075640</td><td align="char" char="." rowspan="1" colspan="1">1006.21</td><td align="char" char="." rowspan="1" colspan="1">197.65</td><td align="char" char="." rowspan="1" colspan="1">5.09</td><td align="right" rowspan="1" colspan="1">4.56E-06</td><td align="left" rowspan="1" colspan="1">protein phosphatase domain-containing protein</td></tr><tr><td align="right" rowspan="1" colspan="1">18</td><td align="right" rowspan="1" colspan="1">EHI_056490</td><td align="char" char="." rowspan="1" colspan="1">2566.49</td><td align="char" char="." rowspan="1" colspan="1">508.88</td><td align="char" char="." rowspan="1" colspan="1">5.04</td><td align="right" rowspan="1" colspan="1">0.00011</td><td align="left" rowspan="1" colspan="1">20 kDa antigen</td></tr><tr><td align="right" rowspan="1" colspan="1">19</td><td align="right" rowspan="1" colspan="1">EHI_075700</td><td align="char" char="." rowspan="1" colspan="1">181.71</td><td align="char" char="." rowspan="1" colspan="1">36.77</td><td align="char" char="." rowspan="1" colspan="1">4.94</td><td align="right" rowspan="1" colspan="1">0.00049</td><td align="left" rowspan="1" colspan="1">casein kinase II regulatory subunit family protein</td></tr><tr><td align="right" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">EHI_164900</td><td align="char" char="." rowspan="1" colspan="1">1176.80</td><td align="char" char="." rowspan="1" colspan="1">246.96</td><td align="char" char="." rowspan="1" colspan="1">4.76</td><td align="right" rowspan="1" colspan="1">8.44E-06</td><td align="left" rowspan="1" colspan="1">Rab family GTPase</td></tr><tr><td align="right" rowspan="1" colspan="1">21</td><td align="right" rowspan="1" colspan="1">EHI_114950</td><td align="char" char="." rowspan="1" colspan="1">127.48</td><td align="char" char="." rowspan="1" colspan="1">27.119</td><td align="char" char="." rowspan="1" colspan="1">4.70</td><td align="right" rowspan="1" colspan="1">0.00046</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">22</td><td align="right" rowspan="1" colspan="1">EHI_039020</td><td align="char" char="." rowspan="1" colspan="1">2024.47</td><td align="char" char="." rowspan="1" colspan="1">448.98</td><td align="char" char="." rowspan="1" colspan="1">4.50</td><td align="right" rowspan="1" colspan="1">2.75E-05</td><td align="left" rowspan="1" colspan="1">Actobindin</td></tr><tr><td align="right" rowspan="1" colspan="1">23</td><td align="right" rowspan="1" colspan="1">EHI_086690</td><td align="char" char="." rowspan="1" colspan="1">3104.05</td><td align="char" char="." rowspan="1" colspan="1">695.45</td><td align="char" char="." rowspan="1" colspan="1">4.46</td><td align="right" rowspan="1" colspan="1">1.25E-05</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">24</td><td align="right" rowspan="1" colspan="1">EHI_175930</td><td align="char" char="." rowspan="1" colspan="1">111.07</td><td align="char" char="." rowspan="1" colspan="1">24.95</td><td align="char" char="." rowspan="1" colspan="1">4.45</td><td align="right" rowspan="1" colspan="1">0.03065</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">EHI_086570</td><td align="char" char="." rowspan="1" colspan="1">169.46</td><td align="char" char="." rowspan="1" colspan="1">38.46</td><td align="char" char="." rowspan="1" colspan="1">4.40</td><td align="right" rowspan="1" colspan="1">0.00069</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">26</td><td align="right" rowspan="1" colspan="1">EHI_028920</td><td align="char" char="." rowspan="1" colspan="1">78.94</td><td align="char" char="." rowspan="1" colspan="1">18.05</td><td align="char" char="." rowspan="1" colspan="1">4.37</td><td align="right" rowspan="1" colspan="1">0.00092</td><td align="left" rowspan="1" colspan="1">heat shock protein</td></tr><tr><td align="right" rowspan="1" colspan="1">27</td><td align="right" rowspan="1" colspan="1">EHI_156560</td><td align="char" char="." rowspan="1" colspan="1">76.06</td><td align="char" char="." rowspan="1" colspan="1">17.79</td><td align="char" char="." rowspan="1" colspan="1">4.27</td><td align="right" rowspan="1" colspan="1">0.00351</td><td align="left" rowspan="1" colspan="1">heat shock protein</td></tr><tr><td align="right" rowspan="1" colspan="1">28</td><td align="right" rowspan="1" colspan="1">EHI_126560</td><td align="char" char="." rowspan="1" colspan="1">372.14</td><td align="char" char="." rowspan="1" colspan="1">92.49</td><td align="char" char="." rowspan="1" colspan="1">4.02</td><td align="right" rowspan="1" colspan="1">3.17E-06</td><td align="left" rowspan="1" colspan="1">AIG1 family protein</td></tr><tr><td align="right" rowspan="1" colspan="1">29</td><td align="right" rowspan="1" colspan="1">EHI_184500</td><td align="char" char="." rowspan="1" colspan="1">257.72</td><td align="char" char="." rowspan="1" colspan="1">64.63</td><td align="char" char="." rowspan="1" colspan="1">3.98</td><td align="right" rowspan="1" colspan="1">6.78E-05</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">30</td><td align="right" rowspan="1" colspan="1">EHI_171750</td><td align="char" char="." rowspan="1" colspan="1">140.38</td><td align="char" char="." rowspan="1" colspan="1">35.85</td><td align="char" char="." rowspan="1" colspan="1">3.91</td><td align="right" rowspan="1" colspan="1">0.00331</td><td align="left" rowspan="1" colspan="1">cysteine synthase 2</td></tr><tr><td align="right" rowspan="1" colspan="1">31</td><td align="right" rowspan="1" colspan="1">EHI_126550</td><td align="char" char="." rowspan="1" colspan="1">225.41</td><td align="char" char="." rowspan="1" colspan="1">57.93</td><td align="char" char="." rowspan="1" colspan="1">3.89</td><td align="right" rowspan="1" colspan="1">0.00042</td><td align="left" rowspan="1" colspan="1">AIG1 family protein</td></tr><tr><td align="right" rowspan="1" colspan="1">32</td><td align="right" rowspan="1" colspan="1">EHI_034710</td><td align="char" char="." rowspan="1" colspan="1">89.31</td><td align="char" char="." rowspan="1" colspan="1">23.34</td><td align="char" char="." rowspan="1" colspan="1">3.82</td><td align="right" rowspan="1" colspan="1">0.00139</td><td align="left" rowspan="1" colspan="1">heat shock protein</td></tr><tr><td align="right" rowspan="1" colspan="1">33</td><td align="right" rowspan="1" colspan="1">EHI_006170</td><td align="char" char="." rowspan="1" colspan="1">979.62</td><td align="char" char="." rowspan="1" colspan="1">257.71</td><td align="char" char="." rowspan="1" colspan="1">3.80</td><td align="right" rowspan="1" colspan="1">0.01065</td><td align="left" rowspan="1" colspan="1">eukaryotic translation initiation factor 6</td></tr><tr><td align="right" rowspan="1" colspan="1">34</td><td align="right" rowspan="1" colspan="1">EHI_085470</td><td align="char" char="." rowspan="1" colspan="1">227.82</td><td align="char" char="." rowspan="1" colspan="1">62.12</td><td align="char" char="." rowspan="1" colspan="1">3.66</td><td align="right" rowspan="1" colspan="1">0.0139</td><td align="left" rowspan="1" colspan="1">splicing factor3B subunit 1</td></tr><tr><td align="right" rowspan="1" colspan="1">35</td><td align="right" rowspan="1" colspan="1">EHI_148550</td><td align="char" char="." rowspan="1" colspan="1">144.75</td><td align="char" char="." rowspan="1" colspan="1">39.82</td><td align="char" char="." rowspan="1" colspan="1">3.63</td><td align="right" rowspan="1" colspan="1">0.00041</td><td align="left" rowspan="1" colspan="1">protein tyrosine kinase domain-containing protein</td></tr><tr><td align="right" rowspan="1" colspan="1">36</td><td align="right" rowspan="1" colspan="1">EHI_042860</td><td align="char" char="." rowspan="1" colspan="1">88.88</td><td align="char" char="." rowspan="1" colspan="1">25.36</td><td align="char" char="." rowspan="1" colspan="1">3.50</td><td align="right" rowspan="1" colspan="1">0.00353</td><td align="left" rowspan="1" colspan="1">heat shock protein</td></tr><tr><td align="right" rowspan="1" colspan="1">37</td><td align="right" rowspan="1" colspan="1">EHI_037550</td><td align="char" char="." rowspan="1" colspan="1">134.83</td><td align="char" char="." rowspan="1" colspan="1">38.51</td><td align="char" char="." rowspan="1" colspan="1">3.50</td><td align="right" rowspan="1" colspan="1">0.00075</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">38</td><td align="right" rowspan="1" colspan="1">EHI_123830</td><td align="char" char="." rowspan="1" colspan="1">380.95</td><td align="char" char="." rowspan="1" colspan="1">109.06</td><td align="char" char="." rowspan="1" colspan="1">3.49</td><td align="right" rowspan="1" colspan="1">0.00598</td><td align="left" rowspan="1" colspan="1">DNA mismatch repair protein Msh2</td></tr><tr><td align="right" rowspan="1" colspan="1">39</td><td align="right" rowspan="1" colspan="1">EHI_060340</td><td align="char" char="." rowspan="1" colspan="1">625.57</td><td align="char" char="." rowspan="1" colspan="1">179.63</td><td align="char" char="." rowspan="1" colspan="1">3.48</td><td align="right" rowspan="1" colspan="1">0.00033</td><td align="left" rowspan="1" colspan="1">cysteine synthase A</td></tr><tr><td align="right" rowspan="1" colspan="1">40</td><td align="right" rowspan="1" colspan="1">EHI_022620</td><td align="char" char="." rowspan="1" colspan="1">100.01</td><td align="char" char="." rowspan="1" colspan="1">29.34</td><td align="char" char="." rowspan="1" colspan="1">3.40</td><td align="right" rowspan="1" colspan="1">0.00090</td><td align="left" rowspan="1" colspan="1">heat shock protein</td></tr><tr><td align="right" rowspan="1" colspan="1">41</td><td align="right" rowspan="1" colspan="1">EHI_169470</td><td align="char" char="." rowspan="1" colspan="1">12932.23</td><td align="char" char="." rowspan="1" colspan="1">3978.28</td><td align="char" char="." rowspan="1" colspan="1">3.25</td><td align="right" rowspan="1" colspan="1">0.00136</td><td align="left" rowspan="1" colspan="1">fructose-1,6-bisphosphate aldolase</td></tr><tr><td align="right" rowspan="1" colspan="1">42</td><td align="right" rowspan="1" colspan="1">EHI_086520</td><td align="char" char="." rowspan="1" colspan="1">244.38</td><td align="char" char="." rowspan="1" colspan="1">76.36</td><td align="char" char="." rowspan="1" colspan="1">3.20</td><td align="right" rowspan="1" colspan="1">0.00127</td><td align="left" rowspan="1" colspan="1">3' exoribonuclease family protein</td></tr><tr><td align="right" rowspan="1" colspan="1">43</td><td align="right" rowspan="1" colspan="1">EHI_177570</td><td align="char" char="." rowspan="1" colspan="1">421.06</td><td align="char" char="." rowspan="1" colspan="1">134.05</td><td align="char" char="." rowspan="1" colspan="1">3.14</td><td align="right" rowspan="1" colspan="1">0.00123</td><td align="left" rowspan="1" colspan="1">RNA 3'-terminal phosphate cyclase</td></tr><tr><td align="right" rowspan="1" colspan="1">44</td><td align="right" rowspan="1" colspan="1">EHI_116830</td><td align="char" char="." rowspan="1" colspan="1">1096.68</td><td align="char" char="." rowspan="1" colspan="1">353.71</td><td align="char" char="." rowspan="1" colspan="1">3.10</td><td align="right" rowspan="1" colspan="1">3.47E-05</td><td align="left" rowspan="1" colspan="1"><sc>d</sc>-phosphoglycerate dehydrogenase</td></tr><tr><td align="right" rowspan="1" colspan="1">45</td><td align="right" rowspan="1" colspan="1">EHI_075710</td><td align="char" char="." rowspan="1" colspan="1">187.29</td><td align="char" char="." rowspan="1" colspan="1">60.76</td><td align="char" char="." rowspan="1" colspan="1">3.08</td><td align="right" rowspan="1" colspan="1">0.03569</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">46</td><td align="right" rowspan="1" colspan="1">EHI_086540</td><td align="char" char="." rowspan="1" colspan="1">205.49</td><td align="char" char="." rowspan="1" colspan="1">66.68</td><td align="char" char="." rowspan="1" colspan="1">3.08</td><td align="right" rowspan="1" colspan="1">0.00933</td><td align="left" rowspan="1" colspan="1">replication factor C subunit 4</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Padj: Adjusted <italic>p</italic>-value, SN: Serial number</p></fn></table-wrap-foot></table-wrap><table-wrap id="ppat.1005853.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.t003</object-id><label>Table 3</label><caption><title>Genes differentially more highly expressed in clone B2<sup>p</sup> than in clone A1<sup>np</sup> (threshold &#x02265; 3.0, padj &#x02264; 0.05).</title></caption><alternatives><graphic id="ppat.1005853.t003g" xlink:href="ppat.1005853.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">SN</th><th align="center" rowspan="1" colspan="1">Gene ID</th><th align="center" colspan="2" rowspan="1">Expression level</th><th align="center" rowspan="1" colspan="1">Fold change</th><th align="center" rowspan="1" colspan="1">padj</th><th align="left" rowspan="1" colspan="1">Product</th></tr><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Clone B2<sup>p</sup></th><th align="center" rowspan="1" colspan="1">Clone A1<sup>np</sup></th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">EHI_127670</td><td align="char" char="." rowspan="1" colspan="1">2314.73</td><td align="char" char="." rowspan="1" colspan="1">12.01</td><td align="char" char="." rowspan="1" colspan="1">192.59</td><td align="right" rowspan="1" colspan="1">0.00029</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">EHI_144490</td><td align="char" char="." rowspan="1" colspan="1">3579.49</td><td align="char" char="." rowspan="1" colspan="1">19.75</td><td align="char" char="." rowspan="1" colspan="1">181.19</td><td align="right" rowspan="1" colspan="1">8.61E-45</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">EHI_169670</td><td align="char" char="." rowspan="1" colspan="1">2551.64</td><td align="char" char="." rowspan="1" colspan="1">27.28</td><td align="char" char="." rowspan="1" colspan="1">93.5</td><td align="right" rowspan="1" colspan="1">1.59E-08</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">EHI_050490</td><td align="char" char="." rowspan="1" colspan="1">25.89</td><td align="char" char="." rowspan="1" colspan="1">0.46</td><td align="char" char="." rowspan="1" colspan="1">55.61</td><td align="right" rowspan="1" colspan="1">6.78E-05</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">EHI_062080</td><td align="char" char="." rowspan="1" colspan="1">123.01</td><td align="char" char="." rowspan="1" colspan="1">5.33</td><td align="char" char="." rowspan="1" colspan="1">23.04</td><td align="right" rowspan="1" colspan="1">0.00073</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">EHI_178610</td><td align="char" char="." rowspan="1" colspan="1">1265.3</td><td align="char" char="." rowspan="1" colspan="1">81.56</td><td align="char" char="." rowspan="1" colspan="1">15.51</td><td align="right" rowspan="1" colspan="1">9.25E-07</td><td align="left" rowspan="1" colspan="1">tyrosine kinase</td></tr><tr><td align="right" rowspan="1" colspan="1">7</td><td align="right" rowspan="1" colspan="1">EHI_013240</td><td align="char" char="." rowspan="1" colspan="1">1500.57</td><td align="char" char="." rowspan="1" colspan="1">104.17</td><td align="char" char="." rowspan="1" colspan="1">14.4</td><td align="right" rowspan="1" colspan="1">2.36E-27</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">8</td><td align="right" rowspan="1" colspan="1">EHI_076370</td><td align="char" char="." rowspan="1" colspan="1">29.83</td><td align="char" char="." rowspan="1" colspan="1">2.31</td><td align="char" char="." rowspan="1" colspan="1">12.86</td><td align="right" rowspan="1" colspan="1">0.00073</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">9</td><td align="right" rowspan="1" colspan="1">EHI_121820</td><td align="char" char="." rowspan="1" colspan="1">937.251</td><td align="char" char="." rowspan="1" colspan="1">73.14</td><td align="char" char="." rowspan="1" colspan="1">12.81</td><td align="right" rowspan="1" colspan="1">6.82E-27</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">EHI_111330</td><td align="char" char="." rowspan="1" colspan="1">70.77</td><td align="char" char="." rowspan="1" colspan="1">7.35</td><td align="char" char="." rowspan="1" colspan="1">9.62</td><td align="right" rowspan="1" colspan="1">1.38E-06</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">11</td><td align="right" rowspan="1" colspan="1">EHI_192510</td><td align="char" char="." rowspan="1" colspan="1">110.82</td><td align="char" char="." rowspan="1" colspan="1">12.8</td><td align="char" char="." rowspan="1" colspan="1">8.65</td><td align="right" rowspan="1" colspan="1">0.04327</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">12</td><td align="right" rowspan="1" colspan="1">EHI_017760</td><td align="char" char="." rowspan="1" colspan="1">343.35</td><td align="char" char="." rowspan="1" colspan="1">43.45</td><td align="char" char="." rowspan="1" colspan="1">7.9</td><td align="right" rowspan="1" colspan="1">2.97E-05</td><td align="left" rowspan="1" colspan="1">tyrosine kinase</td></tr><tr><td align="right" rowspan="1" colspan="1">13</td><td align="right" rowspan="1" colspan="1">EHI_165190</td><td align="char" char="." rowspan="1" colspan="1">84.71</td><td align="char" char="." rowspan="1" colspan="1">12.04</td><td align="char" char="." rowspan="1" colspan="1">7.03</td><td align="right" rowspan="1" colspan="1">2.46E-05</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">14</td><td align="right" rowspan="1" colspan="1">EHI_014170</td><td align="char" char="." rowspan="1" colspan="1">4757.56</td><td align="char" char="." rowspan="1" colspan="1">803.79</td><td align="char" char="." rowspan="1" colspan="1">5.91</td><td align="right" rowspan="1" colspan="1">9.48E-16</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">15</td><td align="right" rowspan="1" colspan="1">EHI_101630</td><td align="char" char="." rowspan="1" colspan="1">316.38</td><td align="char" char="." rowspan="1" colspan="1">68.53</td><td align="char" char="." rowspan="1" colspan="1">4.61</td><td align="right" rowspan="1" colspan="1">0.03397</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">16</td><td align="right" rowspan="1" colspan="1">EHI_144610</td><td align="char" char="." rowspan="1" colspan="1">2146.29</td><td align="char" char="." rowspan="1" colspan="1">505.62</td><td align="char" char="." rowspan="1" colspan="1">4.24</td><td align="right" rowspan="1" colspan="1">0.00275</td><td align="left" rowspan="1" colspan="1">methionine gamma-lyase</td></tr><tr><td align="right" rowspan="1" colspan="1">17</td><td align="right" rowspan="1" colspan="1">EHI_029360</td><td align="char" char="." rowspan="1" colspan="1">308.73</td><td align="char" char="." rowspan="1" colspan="1">74.75</td><td align="char" char="." rowspan="1" colspan="1">4.13</td><td align="right" rowspan="1" colspan="1">0.02649</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">18</td><td align="right" rowspan="1" colspan="1">EHI_057550</td><td align="char" char="." rowspan="1" colspan="1">1835.39</td><td align="char" char="." rowspan="1" colspan="1">465.22</td><td align="char" char="." rowspan="1" colspan="1">3.94</td><td align="right" rowspan="1" colspan="1">0.00063</td><td align="left" rowspan="1" colspan="1">methionine gamma-lyase</td></tr><tr><td align="right" rowspan="1" colspan="1">19</td><td align="right" rowspan="1" colspan="1">EHI_029380</td><td align="char" char="." rowspan="1" colspan="1">49.86</td><td align="char" char="." rowspan="1" colspan="1">12.94</td><td align="char" char="." rowspan="1" colspan="1">3.85</td><td align="right" rowspan="1" colspan="1">0.02703</td><td align="left" rowspan="1" colspan="1">Thioredoxin</td></tr><tr><td align="right" rowspan="1" colspan="1">20</td><td align="right" rowspan="1" colspan="1">EHI_176590</td><td align="char" char="." rowspan="1" colspan="1">226.19</td><td align="char" char="." rowspan="1" colspan="1">60.29</td><td align="char" char="." rowspan="1" colspan="1">3.75</td><td align="right" rowspan="1" colspan="1">0.00115</td><td align="left" rowspan="1" colspan="1">AIG1 family protein</td></tr><tr><td align="right" rowspan="1" colspan="1">21</td><td align="right" rowspan="1" colspan="1">EHI_150770</td><td align="char" char="." rowspan="1" colspan="1">752.48</td><td align="char" char="." rowspan="1" colspan="1">205.27</td><td align="char" char="." rowspan="1" colspan="1">3.66</td><td align="right" rowspan="1" colspan="1">0.00024</td><td align="left" rowspan="1" colspan="1">heat shock protein 70</td></tr><tr><td align="right" rowspan="1" colspan="1">22</td><td align="right" rowspan="1" colspan="1">EHI_197980</td><td align="char" char="." rowspan="1" colspan="1">176.61</td><td align="char" char="." rowspan="1" colspan="1">49.70</td><td align="char" char="." rowspan="1" colspan="1">3.55</td><td align="right" rowspan="1" colspan="1">4.18E-05</td><td align="left" rowspan="1" colspan="1">Myb family DNA-binding protein</td></tr><tr><td align="right" rowspan="1" colspan="1">23</td><td align="right" rowspan="1" colspan="1">EHI_104570</td><td align="char" char="." rowspan="1" colspan="1">2203.52</td><td align="char" char="." rowspan="1" colspan="1">649.79</td><td align="char" char="." rowspan="1" colspan="1">3.39</td><td align="right" rowspan="1" colspan="1">0.00020</td><td align="left" rowspan="1" colspan="1">ubiquitin ligase</td></tr><tr><td align="right" rowspan="1" colspan="1">24</td><td align="right" rowspan="1" colspan="1">EHI_063550</td><td align="char" char="." rowspan="1" colspan="1">423.11</td><td align="char" char="." rowspan="1" colspan="1">126.66</td><td align="char" char="." rowspan="1" colspan="1">3.34</td><td align="right" rowspan="1" colspan="1">4.60E-06</td><td align="left" rowspan="1" colspan="1">Myb-like DNA-binding domain-containing protein</td></tr><tr><td align="right" rowspan="1" colspan="1">25</td><td align="right" rowspan="1" colspan="1">EHI_062970</td><td align="char" char="." rowspan="1" colspan="1">128.26</td><td align="char" char="." rowspan="1" colspan="1">38.68</td><td align="char" char="." rowspan="1" colspan="1">3.31</td><td align="right" rowspan="1" colspan="1">0.00524</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">26</td><td align="right" rowspan="1" colspan="1">EHI_087000</td><td align="char" char="." rowspan="1" colspan="1">502.04</td><td align="char" char="." rowspan="1" colspan="1">153.12</td><td align="char" char="." rowspan="1" colspan="1">3.27</td><td align="right" rowspan="1" colspan="1">0.01391</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">27</td><td align="right" rowspan="1" colspan="1">EHI_033700</td><td align="char" char="." rowspan="1" colspan="1">560.27</td><td align="char" char="." rowspan="1" colspan="1">172.86</td><td align="char" char="." rowspan="1" colspan="1">3.24</td><td align="right" rowspan="1" colspan="1">0.00033</td><td align="left" rowspan="1" colspan="1">RecF/RecN/SMC domain-containing protein</td></tr><tr><td align="right" rowspan="1" colspan="1">28</td><td align="right" rowspan="1" colspan="1">EHI_063580</td><td align="char" char="." rowspan="1" colspan="1">167.63</td><td align="char" char="." rowspan="1" colspan="1">52.23</td><td align="char" char="." rowspan="1" colspan="1">3.20</td><td align="right" rowspan="1" colspan="1">0.00160</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">29</td><td align="right" rowspan="1" colspan="1">EHI_131490</td><td align="char" char="." rowspan="1" colspan="1">226.62</td><td align="char" char="." rowspan="1" colspan="1">73.84</td><td align="char" char="." rowspan="1" colspan="1">3.06</td><td align="right" rowspan="1" colspan="1">0.00049</td><td align="left" rowspan="1" colspan="1">leucine-rich repeat protein. BspA family</td></tr><tr><td align="right" rowspan="1" colspan="1">30</td><td align="right" rowspan="1" colspan="1">EHI_020250</td><td align="char" char="." rowspan="1" colspan="1">635.65</td><td align="char" char="." rowspan="1" colspan="1">207.17</td><td align="char" char="." rowspan="1" colspan="1">3.06</td><td align="right" rowspan="1" colspan="1">0.04815</td><td align="left" rowspan="1" colspan="1">lecithin:cholesterol acyltransferase domain-containing protein</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Padj: Adjusted <italic>p</italic>-value, SN: Serial number</p></fn></table-wrap-foot></table-wrap><p>The greatest differences, with expression fold changes ~20&#x02013;200, concerned genes encoding three C2 domain proteins, three Rab family GTPases, cell surface protease gp63 and one hypothetical protein (EHI_074080), whose expression was higher in clone A1<sup>np</sup>; and five genes encoding hypothetical proteins EHI_127670, EHI_144490, EHI_169670, EHI_050490 and EHI_062080, with higher expression in clone B2<sup>p</sup>. The majority of the identified genes showed 3-4-fold differential expression (Tables <xref ref-type="table" rid="ppat.1005853.t002">2</xref> and <xref ref-type="table" rid="ppat.1005853.t003">3</xref>). The detected differential expression was verified by quantitative real-time PCR (qPCR) for 26 genes. Results of next generation sequencing were confirmed for all the analysed genes, with the exception of EHI_056490 (threshold &#x02265; 2 fold, <xref ref-type="table" rid="ppat.1005853.t004">Table 4</xref>).</p><table-wrap id="ppat.1005853.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.t004</object-id><label>Table 4</label><caption><title>mRNASeq and quantitative real-time PCR data for genes whose expression was at least &#x02265; 3-fold higher in clone A1<sup>np</sup> than in clone B2<sup>p</sup>.</title></caption><alternatives><graphic id="ppat.1005853.t004g" xlink:href="ppat.1005853.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="2" rowspan="1">ddCT<xref ref-type="table-fn" rid="t004fn001"><sup>a</sup></xref></th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Gene ID</th><th align="left" rowspan="1" colspan="1">mRNASeq (fold change)</th><th align="left" rowspan="1" colspan="1">Clone A1<sup>np</sup></th><th align="left" rowspan="1" colspan="1">Clone B2<sup>p</sup> (calibrator)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">EhC2-3 (C2 domain-containing protein)</td><td align="left" rowspan="1" colspan="1">EHI_015290</td><td align="char" char="." rowspan="1" colspan="1">223.47</td><td align="left" rowspan="1" colspan="1">254.6 &#x000b1; 229.6<xref ref-type="table-fn" rid="t004fn003">**</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">EhMP8-2 (cell surface protease gp63)</td><td align="left" rowspan="1" colspan="1">EHI_042870</td><td align="char" char="." rowspan="1" colspan="1">149.12</td><td align="left" rowspan="1" colspan="1">134.7 &#x000b1; 54.93<xref ref-type="table-fn" rid="t004fn003">**</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">EhRab7D (Rab family GTPase)</td><td align="left" rowspan="1" colspan="1">EHI_082070</td><td align="char" char="." rowspan="1" colspan="1">94.48</td><td align="left" rowspan="1" colspan="1">22.5 &#x000b1; 15.64<xref ref-type="table-fn" rid="t004fn004">***</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">EhC2-5 (C2 domain-containing protein)</td><td align="left" rowspan="1" colspan="1">EHI_059860</td><td align="char" char="." rowspan="1" colspan="1">77.14</td><td align="left" rowspan="1" colspan="1">490.2 &#x000b1; 88.81<xref ref-type="table-fn" rid="t004fn002">*</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">EhC2-2 (C2 domain-containing protein)</td><td align="left" rowspan="1" colspan="1">EHI_118130</td><td align="char" char="." rowspan="1" colspan="1">60.31</td><td align="left" rowspan="1" colspan="1">66.2 &#x000b1; 3.3<xref ref-type="table-fn" rid="t004fn002">*</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">EhRab7E (Rab family GTPase)</td><td align="left" rowspan="1" colspan="1">EHI_169280</td><td align="char" char="." rowspan="1" colspan="1">50.61</td><td align="left" rowspan="1" colspan="1">42.1 &#x000b1; 28.31<xref ref-type="table-fn" rid="t004fn005">****</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_074080</td><td align="char" char="." rowspan="1" colspan="1">32.95</td><td align="left" rowspan="1" colspan="1">229.3 &#x000b1; 99.95<xref ref-type="table-fn" rid="t004fn004">***</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">EhRab7G (Rab family GTPase)</td><td align="left" rowspan="1" colspan="1">EHI_187090</td><td align="char" char="." rowspan="1" colspan="1">25.44</td><td align="left" rowspan="1" colspan="1">28.2 &#x000b1; 24.52<xref ref-type="table-fn" rid="t004fn004">***</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_005657</td><td align="char" char="." rowspan="1" colspan="1">7.06</td><td align="left" rowspan="1" colspan="1">2.87 &#x000b1; 0.4<xref ref-type="table-fn" rid="t004fn005">****</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">EhCAAX (CAAX prenyl protease)</td><td align="left" rowspan="1" colspan="1">EHI_075660</td><td align="char" char="." rowspan="1" colspan="1">5.84</td><td align="left" rowspan="1" colspan="1">2.5 &#x000b1; 0.83 <xref ref-type="table-fn" rid="t004fn003">**</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_075690</td><td align="char" char="." rowspan="1" colspan="1">5.50</td><td align="left" rowspan="1" colspan="1">5.6 &#x000b1; 2.8<xref ref-type="table-fn" rid="t004fn004">***</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein phosphatase domain-containing protein</td><td align="left" rowspan="1" colspan="1">EHI_075640</td><td align="char" char="." rowspan="1" colspan="1">5.09</td><td align="left" rowspan="1" colspan="1">2.8 &#x000b1; 0.3<xref ref-type="table-fn" rid="t004fn002">*</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">20 kDa antigen</td><td align="left" rowspan="1" colspan="1">EHI_056490</td><td align="char" char="." rowspan="1" colspan="1">5.04</td><td align="left" rowspan="1" colspan="1">1.9 &#x000b1; 0.14<xref ref-type="table-fn" rid="t004fn002">*</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Casein kinase II regulatory subunit family protein</td><td align="left" rowspan="1" colspan="1">EHI_075700</td><td align="char" char="." rowspan="1" colspan="1">4.94</td><td align="left" rowspan="1" colspan="1">2.7 &#x000b1; 1<xref ref-type="table-fn" rid="t004fn002">*</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_086690</td><td align="char" char="." rowspan="1" colspan="1">4.46</td><td align="left" rowspan="1" colspan="1">3.3 &#x000b1; 0.13<xref ref-type="table-fn" rid="t004fn002">*</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Replication factor C subunit 4</td><td align="left" rowspan="1" colspan="1">EHI_086540</td><td align="char" char="." rowspan="1" colspan="1">3.08</td><td align="left" rowspan="1" colspan="1">2.5 &#x000b1; 0.23<xref ref-type="table-fn" rid="t004fn002">*</xref></td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>Clone A1</bold><sup><bold>np</bold></sup>
<bold>(calibrator)</bold></td><td align="left" rowspan="1" colspan="1"><bold>B2</bold><sup><bold>p</bold></sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_127670</td><td align="char" char="." rowspan="1" colspan="1">192.59</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">13.5 &#x000b1; 5<xref ref-type="table-fn" rid="t004fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_144490</td><td align="char" char="." rowspan="1" colspan="1">181.19</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">38 &#x000b1; 6.4<xref ref-type="table-fn" rid="t004fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">EhC2-DIL1 (hypothetical protein)</td><td align="left" rowspan="1" colspan="1">EHI_169670</td><td align="char" char="." rowspan="1" colspan="1">93.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">58.5 &#x000b1; 58<xref ref-type="table-fn" rid="t004fn005">****</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Tyrosine kinase</td><td align="left" rowspan="1" colspan="1">EHI_178610</td><td align="char" char="." rowspan="1" colspan="1">15.51</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">14.8 &#x000b1; 9<xref ref-type="table-fn" rid="t004fn003">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_013240</td><td align="char" char="." rowspan="1" colspan="1">14.4</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">6.9 &#x000b1; 0.07<xref ref-type="table-fn" rid="t004fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_121820</td><td align="char" char="." rowspan="1" colspan="1">12.81</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">6 &#x000b1; 1.3<xref ref-type="table-fn" rid="t004fn003">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_111330</td><td align="char" char="." rowspan="1" colspan="1">9.62</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">9.4 &#x000b1; 1.2<xref ref-type="table-fn" rid="t004fn003">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Hypothetical protein</td><td align="left" rowspan="1" colspan="1">EHI_165190</td><td align="char" char="." rowspan="1" colspan="1">7.03</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">4.8 &#x000b1; 2.6<xref ref-type="table-fn" rid="t004fn003">**</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">EhC2-DIL2 (hypothetical protein)</td><td align="left" rowspan="1" colspan="1">EHI_014170</td><td align="char" char="." rowspan="1" colspan="1">5.91</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">57.4 &#x000b1; 38.1<xref ref-type="table-fn" rid="t004fn005">****</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Methionine gamma-lyase</td><td align="left" rowspan="1" colspan="1">EHI_144610</td><td align="char" char="." rowspan="1" colspan="1">4.24</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2.6 &#x000b1; 0.4<xref ref-type="table-fn" rid="t004fn002">*</xref></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p><sup>a</sup>Relative differences in gene expression; ehactin was used as a normalizer.</p></fn><fn id="t004fn002"><p><italic>*p</italic> &#x02264; 0.05,</p></fn><fn id="t004fn003"><p><italic>**p</italic> &#x02264; 0.005,</p></fn><fn id="t004fn004"><p><italic>***p</italic> &#x02264; 0.001,</p></fn><fn id="t004fn005"><p><italic>****p</italic> &#x02264; 0.0001.</p></fn></table-wrap-foot></table-wrap><p>Most of the identified genes encode proteins with unknown function. Some of these hypothetical proteins contain functional domains, e.g., C2 domains, phosphatase domains, tyrosine kinase domains, RecF/RecN/SMC domains and lecithin:cholesterol acyltransferase domains. Proteins with known functions up-regulated in clone A1<sup>np</sup>, when compared with clone B2<sup>p</sup>, mainly included Rab family proteins, peptidases and heat shock proteins. Putative function could be assigned to only 6/30 genes identified as more highly expressed in clone B2<sup>p</sup> in comparison with clone A1<sup>np</sup> (e.g., tyrosine kinase, methionine gamma-lyase, thioredoxin) (Tables <xref ref-type="table" rid="ppat.1005853.t002">2</xref> and <xref ref-type="table" rid="ppat.1005853.t003">3</xref>).</p><p>Comparisons of the two B-clones, B2<sup>p</sup> and B8<sup>np</sup>, revealed only 19 differentially expressed genes. Twelve genes were expressed at higher levels in clone B8<sup>np</sup> in comparison with clone B2<sup>p</sup>, and seven genes were expressed more highly in B2<sup>p</sup> in comparison with B8<sup>np</sup> (Tables <xref ref-type="table" rid="ppat.1005853.t005">5</xref> and <xref ref-type="table" rid="ppat.1005853.t006">6</xref>, <xref ref-type="supplementary-material" rid="ppat.1005853.s003">S3 Table</xref>). The corresponding proteins assigned to EHI_039020 and EHI_088020 were found to be part of the surface proteome of <italic>E</italic>. <italic>histolytica</italic> [<xref rid="ppat.1005853.ref013" ref-type="bibr">13</xref>]. Fold change &#x02265; 10 was detected for only three genes. These genes encoded two hypothetical proteins and a leucine-rich repeat-containing protein. All these genes were more highly expressed in B2<sup>p</sup> in comparison with B8<sup>np</sup>. As observed in the A1<sup>np</sup>/B2<sup>p</sup> comparison, the majority of the identified genes showed 3-4-fold differential expression (Tables <xref ref-type="table" rid="ppat.1005853.t005">5</xref> and <xref ref-type="table" rid="ppat.1005853.t006">6</xref>). The majority (11/19) of the genes encoded hypothetical proteins. The remaining genes were annotated as galactose-inhibitable lectin 35 kDa subunit, phosphoserine aminotransferase, actobindin, alcohol dehydrogenase, AIG1 family protein and methionine gamma-lyase. However, only galactose-inhibitable lectin 35 kDa subunit and methionine gamma-lyase have been biochemically characterised in <italic>E</italic>. <italic>histolytica</italic> [<xref rid="ppat.1005853.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="ppat.1005853.ref017" ref-type="bibr">17</xref>].</p><table-wrap id="ppat.1005853.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.t005</object-id><label>Table 5</label><caption><title>Genes differentially more highly expressed in clone B8<sup>np</sup> than in clone B2<sup>p</sup> (threshold &#x02265; 3.0, padj &#x02264; 0.05).</title></caption><alternatives><graphic id="ppat.1005853.t005g" xlink:href="ppat.1005853.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">SN</th><th align="center" rowspan="1" colspan="1">Gene ID</th><th align="center" colspan="2" rowspan="1">Expression level</th><th align="center" rowspan="1" colspan="1">Fold change</th><th align="center" rowspan="1" colspan="1">padj</th><th align="left" rowspan="1" colspan="1">Product</th></tr><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Clone B8<sup>np</sup></th><th align="center" rowspan="1" colspan="1">Clone B2<sup>p</sup></th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">EHI_062960</td><td align="char" char="." rowspan="1" colspan="1">64.90</td><td align="char" char="." rowspan="1" colspan="1">7.85</td><td align="char" char="." rowspan="1" colspan="1">8.26</td><td align="right" rowspan="1" colspan="1">0.00806</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">EHI_183400</td><td align="char" char="." rowspan="1" colspan="1">37.64</td><td align="char" char="." rowspan="1" colspan="1">5.66</td><td align="char" char="." rowspan="1" colspan="1">6.64</td><td align="right" rowspan="1" colspan="1">0.02770</td><td align="left" rowspan="1" colspan="1">galactose-inhibitable lectin 35 kDa subunit</td></tr><tr><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">EHI_048140</td><td align="char" char="." rowspan="1" colspan="1">771.02</td><td align="char" char="." rowspan="1" colspan="1">160.91</td><td align="char" char="." rowspan="1" colspan="1">4.79</td><td align="right" rowspan="1" colspan="1">0.00114</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">EHI_058920</td><td align="char" char="." rowspan="1" colspan="1">1548.15</td><td align="char" char="." rowspan="1" colspan="1">360.65</td><td align="char" char="." rowspan="1" colspan="1">4.29</td><td align="right" rowspan="1" colspan="1">7.462E-08</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">EHI_026360</td><td align="char" char="." rowspan="1" colspan="1">137.56</td><td align="char" char="." rowspan="1" colspan="1">33.05</td><td align="char" char="." rowspan="1" colspan="1">4.16</td><td align="right" rowspan="1" colspan="1">0.00114</td><td align="left" rowspan="1" colspan="1">phosphoserine aminotransferase</td></tr><tr><td align="right" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">EHI_037160</td><td align="char" char="." rowspan="1" colspan="1">102.17</td><td align="char" char="." rowspan="1" colspan="1">26.67</td><td align="char" char="." rowspan="1" colspan="1">3.83</td><td align="right" rowspan="1" colspan="1">0.01207</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">7</td><td align="right" rowspan="1" colspan="1">EHI_039020</td><td align="char" char="." rowspan="1" colspan="1">356.95</td><td align="char" char="." rowspan="1" colspan="1">101.96</td><td align="char" char="." rowspan="1" colspan="1">3.50</td><td align="right" rowspan="1" colspan="1">0.03229</td><td align="left" rowspan="1" colspan="1">Actobindin</td></tr><tr><td align="right" rowspan="1" colspan="1">8</td><td align="right" rowspan="1" colspan="1">EHI_088020</td><td align="char" char="." rowspan="1" colspan="1">821.37</td><td align="char" char="." rowspan="1" colspan="1">234.45</td><td align="char" char="." rowspan="1" colspan="1">3.50</td><td align="right" rowspan="1" colspan="1">0.28544</td><td align="left" rowspan="1" colspan="1">alcohol dehydrogenase</td></tr><tr><td align="right" rowspan="1" colspan="1">9</td><td align="right" rowspan="1" colspan="1">EHI_151930</td><td align="char" char="." rowspan="1" colspan="1">521.04</td><td align="char" char="." rowspan="1" colspan="1">156.15</td><td align="char" char="." rowspan="1" colspan="1">3.33</td><td align="right" rowspan="1" colspan="1">0.00017</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">10</td><td align="right" rowspan="1" colspan="1">EHI_160670</td><td align="char" char="." rowspan="1" colspan="1">252.40</td><td align="char" char="." rowspan="1" colspan="1">76.60</td><td align="char" char="." rowspan="1" colspan="1">3.29</td><td align="right" rowspan="1" colspan="1">0.00514</td><td align="left" rowspan="1" colspan="1">alcohol dehydrogenase 3</td></tr><tr><td align="right" rowspan="1" colspan="1">11</td><td align="right" rowspan="1" colspan="1">EHI_180390</td><td align="char" char="." rowspan="1" colspan="1">216.17</td><td align="char" char="." rowspan="1" colspan="1">69.98</td><td align="char" char="." rowspan="1" colspan="1">3.09</td><td align="right" rowspan="1" colspan="1">0.00611</td><td align="left" rowspan="1" colspan="1">AIG1 family protein</td></tr><tr><td align="right" rowspan="1" colspan="1">12</td><td align="right" rowspan="1" colspan="1">EHI_056490</td><td align="char" char="." rowspan="1" colspan="1">290.45</td><td align="char" char="." rowspan="1" colspan="1">98.02</td><td align="char" char="." rowspan="1" colspan="1">2.96</td><td align="right" rowspan="1" colspan="1">0.00514</td><td align="left" rowspan="1" colspan="1">20 kDa antigen</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Padj: Adjusted <italic>p</italic>-value, SN: Serial number</p></fn></table-wrap-foot></table-wrap><table-wrap id="ppat.1005853.t006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.t006</object-id><label>Table 6</label><caption><title>Genes differentially more highly expressed in clone B2<sup>p</sup> than in clone B8<sup>np</sup> (threshold &#x02265; 3.0, padj &#x02264; 0.05).</title></caption><alternatives><graphic id="ppat.1005853.t006g" xlink:href="ppat.1005853.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">SN</th><th align="center" rowspan="1" colspan="1">Gene ID</th><th align="center" colspan="2" rowspan="1">Expression level</th><th align="center" rowspan="1" colspan="1">Fold change</th><th align="center" rowspan="1" colspan="1">padj</th><th align="left" rowspan="1" colspan="1">Product</th></tr><tr><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Clone B2<sup>p</sup></th><th align="center" rowspan="1" colspan="1">Clone B8<sup>p</sup></th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="right" rowspan="1" colspan="1">1</td><td align="right" rowspan="1" colspan="1">EHI_127670</td><td align="char" char="." rowspan="1" colspan="1">806.03</td><td align="char" char="." rowspan="1" colspan="1">17.69657648</td><td align="char" char="." rowspan="1" colspan="1">45.54</td><td align="right" rowspan="1" colspan="1">0.00017</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">2</td><td align="right" rowspan="1" colspan="1">EHI_073680</td><td align="char" char="." rowspan="1" colspan="1">149.05</td><td align="char" char="." rowspan="1" colspan="1">19.46774451</td><td align="char" char="." rowspan="1" colspan="1">14.31</td><td align="right" rowspan="1" colspan="1">8.914E-17</td><td align="left" rowspan="1" colspan="1">leucine-rich repeat-containing protein</td></tr><tr><td align="right" rowspan="1" colspan="1">3</td><td align="right" rowspan="1" colspan="1">EHI_144490</td><td align="char" char="." rowspan="1" colspan="1">1086.69</td><td align="char" char="." rowspan="1" colspan="1">94.76770315</td><td align="char" char="." rowspan="1" colspan="1">11.46</td><td align="right" rowspan="1" colspan="1">5.624E-22</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">4</td><td align="right" rowspan="1" colspan="1">EHI_062080</td><td align="char" char="." rowspan="1" colspan="1">6.71</td><td align="char" char="." rowspan="1" colspan="1">40.72199698</td><td align="char" char="." rowspan="1" colspan="1">6.07</td><td align="right" rowspan="1" colspan="1">0.02179</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">5</td><td align="right" rowspan="1" colspan="1">EHI_191730</td><td align="char" char="." rowspan="1" colspan="1">96.40</td><td align="char" char="." rowspan="1" colspan="1">27.58393181</td><td align="char" char="." rowspan="1" colspan="1">3.49</td><td align="right" rowspan="1" colspan="1">0.01942</td><td align="left" rowspan="1" colspan="1">hypothetical protein</td></tr><tr><td align="right" rowspan="1" colspan="1">6</td><td align="right" rowspan="1" colspan="1">EHI_144610</td><td align="char" char="." rowspan="1" colspan="1">661.91</td><td align="char" char="." rowspan="1" colspan="1">201.7370164</td><td align="char" char="." rowspan="1" colspan="1">3.28</td><td align="right" rowspan="1" colspan="1">0.00017</td><td align="left" rowspan="1" colspan="1">methionine gamma-lyase</td></tr><tr><td align="right" rowspan="1" colspan="1">7</td><td align="right" rowspan="1" colspan="1">EHI_057550</td><td align="char" char="." rowspan="1" colspan="1">556.94</td><td align="char" char="." rowspan="1" colspan="1">175.7481139</td><td align="char" char="." rowspan="1" colspan="1">3.16</td><td align="right" rowspan="1" colspan="1">0.00046</td><td align="left" rowspan="1" colspan="1">methionine gamma-lyase</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t006fn001"><p>Padj: Adjusted <italic>p</italic>-value, SN: Serial number</p></fn></table-wrap-foot></table-wrap><p>Interestingly, only six genes in the two non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup> were similarly regulated vs. pathogenic clone B2<sup>p</sup>. Genes EHI_026360, EHI_039020 and EHI_056490 were up-regulated, and genes EHI_127670, EHI_144490 and EHI_144610 were down-regulated, in clones A1<sup>np</sup> and B8<sup>np</sup> in relation to clone B2<sup>p</sup>. This suggests different mechanisms accounting for the inability of clones A1<sup>np</sup> and B8<sup>np</sup> to induce ALAs.</p></sec><sec id="sec008"><title>Characteristics of the proteins encoded by genes found to be differentially expressed between clone A1<sup>np</sup> and clone B2<sup>p</sup> and/or clone B8<sup>np</sup> and clone B2<sup>p</sup></title><p>In total 89 genes were found to be differentially expressed between clone A1<sup>np</sup> and clone B2<sup>p</sup> and/or between clone B8<sup>np</sup> and clone B2<sup>p</sup>. In a previous study, the transcriptomes of the non-clonal cell lines A and B were compared using a microarray approach [<xref rid="ppat.1005853.ref012" ref-type="bibr">12</xref>]. Here, in total 31 genes were differentially expressed (threshold &#x02265;3-fold). Of the 12 genes with higher expression levels in cell line B in comparison to cell line A, 7 genes had also higher expression levels in clone B2<sup>p</sup> in comparison to clone A1<sup>np</sup>. Out of the 19 genes with higher expression levels in cell line A in comparison to cell line B, 11 genes showed also higher expression in clone A1<sup>np</sup> in comparison to clone B2<sup>p</sup> (<xref ref-type="supplementary-material" rid="ppat.1005853.s004">S4 Table</xref>). Only 8 of the identified 89 genes encoded for proteins containing a signal peptide and 15 genes encoded for proteins containing between 1&#x02013;7 transmembrane domains (<xref ref-type="supplementary-material" rid="ppat.1005853.s004">S4 Table</xref>). In a previous study in which the surface proteome of cell line A was analysed, 693 putative surface-associated proteins were identified [<xref rid="ppat.1005853.ref013" ref-type="bibr">13</xref>]. Out of them 11 showed differential expression between the different clones (<xref ref-type="supplementary-material" rid="ppat.1005853.s004">S4 Table</xref>).</p><p>From the 89 identified genes, 32 encode hypothetical proteins, where no homology to other proteins or protein domains could be identified.</p><p>Furthermore, 3 genes encode for proteins of the C2 superfamily, 4 genes encode for members of the small GTPase superfamily, 10 genes encode for heat shock proteins, 6 genes encode for AIG1 family proteins, 3 genes encode for kinases 2 genes encode for cysteine synthases and 2 genes encode for proteases. Additional 18 genes encode for proteins with other known functions (<xref ref-type="supplementary-material" rid="ppat.1005853.s004">S4 Table</xref>).</p></sec><sec id="sec009"><title>Transfectants overexpressing a selection of the differentially expressed genes and gene involvement in ALA formation</title><p>To investigate whether the differentially expressed genes play a role in ALA formation, their respective overexpressing transfectants were generated. For genes that were more highly expressed in clone A1<sup>np</sup> in comparison with clone B2<sup><italic>p</italic></sup>, 13 overexpressing transfectants of clone B2<sup>p</sup> were generated. These included eight genes that displayed the highest differential expression (&#x0003e;20-fold) and three genes that were also up-regulated in clone B8<sup>np</sup> (EHI_026360, EHI_056490, EHI_039020) (Tables <xref ref-type="table" rid="ppat.1005853.t002">2</xref> and <xref ref-type="table" rid="ppat.1005853.t005">5</xref>). We were unable to generate transfectants overexpressing genes EHI_169280 (<italic>ehrab7e</italic>), EHI_074080, EHI_187090 (<italic>ehrab7g</italic>) and EHI_075660 (<italic>ehcaax</italic>). For all other genes, a relative 2.4&#x02013;235-fold overexpression was obtained (<xref ref-type="supplementary-material" rid="ppat.1005853.s005">S5 Table</xref>). The pathogenic phenotype of the majority of B2<sup>p</sup> transfectants overexpressing genes that were more highly expressed in the non-pathogenic clone A1<sup>np</sup> vs. pathogenic clone B2<sup>p</sup> was unaffected. These also included transfectants that overexpressed three genes regulated in the same manner in clones A1<sup>np</sup> and B8<sup>np</sup>. All these B2<sup>p</sup> transfectants induced ALA formation in mice. Four genes were identified whose overexpression had a dramatic impact on ALA formation. When EHI_015290 (<italic>ehc2-3</italic>), EHI_059860 (<italic>ehc2-5</italic>), EHI_042870 (<italic>ehmp8-2</italic>) or EHI_075690 were overexpressed in clone B2<sup>p</sup>, these clones lost their pathogenic phenotype and produced significantly smaller ALAs than the respective controls (<xref ref-type="fig" rid="ppat.1005853.g005">Fig 5A</xref>).</p><fig id="ppat.1005853.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005853.g005</object-id><label>Fig 5</label><caption><title>Analysis of ALA formation after infecting gerbils with various <italic>E</italic>. <italic>histolytica</italic> transfectants.</title><p>B2<sup>p</sup> (A), A1<sup>np</sup> (B) and B8<sup>np</sup> transfectants (C) overexpressing various genes differentially expressed in clones A1<sup>np</sup> and B2<sup>p</sup> were used to intrahepatically infect mice. Seven days post infection, ALA formation was determined [area of ALA (mm<sup>2</sup>)]. Significance (<italic>p</italic>-values) was established by the Mann-Whitney <italic>U</italic> test. <italic>p</italic>-values were calculated relative to control (pNC transfectants of clone B2<sup>p</sup> (A), A1<sup>np</sup> (B) or B8<sup>np</sup> (c), respectively). *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.005, ***<italic>p</italic> &#x0003c; 0.001, **** <italic>p</italic> &#x0003c; 0.0001, ns: not significant. For detailed information see <xref ref-type="supplementary-material" rid="ppat.1005853.s001">S1 Table</xref>.</p></caption><graphic xlink:href="ppat.1005853.g005"/></fig><p>B2<sup>p</sup> transfectants were generated for 9/12 genes that were expressed at higher levels in clone B8<sup>np</sup> in comparison with clone B2<sup>p</sup>. They showed 4&#x02013;300-fold increased expression in comparison with the control (<xref ref-type="supplementary-material" rid="ppat.1005853.s005">S5 Table</xref>). Overexpression of genes EHI_058920, EHI_088020 and EHI_160670 significantly reduced pathogenicity of clone B2<sup>p</sup> (<xref ref-type="fig" rid="ppat.1005853.g005">Fig 5A</xref>). <italic>In silico</italic> analyses indicated that nucleotide sequences of EHI_088020 and EHI_160670 were identical and that the genes encode an alcohol dehydrogenase. However, the first 480 nucleotides of the EHI_088020 coding region were missing from the EHI_160670 sequence. This may be because the <italic>E</italic>. <italic>histolytica</italic> genome is not yet fully annotated (AmoebaDB, <ext-link ext-link-type="uri" xlink:href="http://amoebadb.org/amoeba/">http://amoebadb.org/amoeba/</ext-link>). Regardless, increased expression of the full-length or truncated gene impacted abscess formation (<xref ref-type="fig" rid="ppat.1005853.g005">Fig 5A</xref>).</p><p>For genes expressed more highly in clone B2<sup>p</sup> in comparison with clone A1<sup>np</sup>, five gene-overexpressing clone A1<sup>np</sup> transfectants were generated, including three genes with an initially detected &#x0003e;90-fold differential expression. Overexpression of EHI_169670 was unsuccessful; however, for all other genes a relative 4&#x02013;490-fold expression was obtained (<xref ref-type="supplementary-material" rid="ppat.1005853.s006">S6 Table</xref>). Overexpression of these genes did not significantly affect ALA formation. However, strikingly, 4/9 mice infected with EHI_127670-overexpressing A1<sup>np</sup> transfectant produced large ALAs (<xref ref-type="fig" rid="ppat.1005853.g005">Fig 5B</xref>).</p><p>Seven genes were more highly expressed in clone B8<sup>np</sup> in comparison with clone B2<sup>p</sup>. Two, EHI_144610 and EHI_057550, were identical and encode methionine gamma-lyase. Four B8<sup>np</sup> transfectants were generated, and all of them showed 3&#x02013;70-fold overexpression in comparison with the control (<xref ref-type="supplementary-material" rid="ppat.1005853.s007">S7 Table</xref>). Similarly to A1<sup>np</sup> transfectants, no significant influence on ALA formation was observed. Interestingly, large ALAs were detected 7 days post infection in 6/9 mice infected with B8<sup>np</sup> transfectant overexpressing EHI_127670 (p = 0.0589), as was observed for infections with A1<sup>np</sup>-EHI_127670 transfectants (p = 0.292) (<xref ref-type="fig" rid="ppat.1005853.g005">Fig 5B and 5C</xref>).</p></sec></sec><sec sec-type="conclusions" id="sec010"><title>Discussion</title><p>Recent studies aiming to identify the differences between the non-pathogenic isolate HM-1:IMSS_A and the closely related but pathogenic isolate HM-1:IMSS_B using proteomic and transcriptomic analyses revealed a surprisingly small overlap between the two approaches [<xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>, <xref rid="ppat.1005853.ref012" ref-type="bibr">12</xref>]. To eliminate the potential experimental limitations associated with cell population heterogeneity, we cloned both mother lines resulting in 12 clones derived from cell line HM-1:IMSS_A (A1&#x02013;A12) and 12 clones derived from cell line HM-1:IMSS_B (B1&#x02013;B12). As expected, all clones derived from cell line HM-1:IMSS_A were unable to form ALAs. Surprisingly, the situation was more complex for clones derived from the HM-1:IMSS_B cell line. Here, only 8/12 clones analysed displayed the pathogenic phenotype of the original cell line. To understand the phenotypically different outcomes, three clones were selected for in-depth analyses. These were pathogenic clone B2<sup>p</sup> and non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup>.</p><p>Interestingly, and in contrast to other pathogenic isolates, the pathogenicity of clone B2<sup>p</sup> remained stable for years without animal passage. Usually, trophozoites become less virulent after long-term culture and pathogenicity retainment requires regular animal passages or at least the addition of cholesterol to the culture medium [<xref rid="ppat.1005853.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="ppat.1005853.ref022" ref-type="bibr">22</xref>].</p><p>Although the mouse model for ALA, has some limitations regarding the artificial route of infection, it is well established [<xref rid="ppat.1005853.ref023" ref-type="bibr">23</xref>&#x02013;<xref rid="ppat.1005853.ref025" ref-type="bibr">25</xref>] and allows in this study to discriminate between pathogenic and less pathogenic clones. Accordingly, the high reproducibility of the differences in the recovery time of the liver between &#x0201e;non-pathogenic&#x0201d;and &#x0201e;pathogenic&#x0201d;<italic>E</italic>. <italic>histolytica</italic> clones opens a stable time frame that enables studying pathogenicity factors involved in liver pathology on a significant level. However, no conclusion can be drawn concerning the process of invasion into the intestinal mucosa, induction of amoebic colitis and immune evasion [<xref rid="ppat.1005853.ref026" ref-type="bibr">26</xref>, <xref rid="ppat.1005853.ref027" ref-type="bibr">27</xref>].</p><p>CPs have been described as major pathogenicity factors of <italic>E</italic>. <italic>histolytica</italic>. In several studies, a direct correlation between CP activity and ALA formation was observed [<xref rid="ppat.1005853.ref019" ref-type="bibr">19</xref>, <xref rid="ppat.1005853.ref028" ref-type="bibr">28</xref>&#x02013;<xref rid="ppat.1005853.ref031" ref-type="bibr">31</xref>]. In addition, ALA formation can be inhibited by specific cysteine peptidase inhibitors, and overexpression and silencing of individual <italic>E</italic>. <italic>histolytica cp</italic> genes can alter the ALAs-inducing ability of amoebae [<xref rid="ppat.1005853.ref003" ref-type="bibr">3</xref>, <xref rid="ppat.1005853.ref006" ref-type="bibr">6</xref>, <xref rid="ppat.1005853.ref032" ref-type="bibr">32</xref>&#x02013;<xref rid="ppat.1005853.ref036" ref-type="bibr">36</xref>]. Furthermore, several studies indicate that especially EhCP-A5 is involved in the invasion process into the intestinal mucosa [<xref rid="ppat.1005853.ref037" ref-type="bibr">37</xref>&#x02013;<xref rid="ppat.1005853.ref039" ref-type="bibr">39</xref>]. In this context, it was shown that EhCP-A5 triggers the production and release of human matrix metalloproteinases (MMPs) through inflammatory cytokine induction. Moreover it cleaves pro-MMP-3 and converts it into active MMP-3. Together, these processes are involved in the ECM remodelling required for tissue invasion [<xref rid="ppat.1005853.ref038" ref-type="bibr">38</xref>]. Furthermore, it was shown that EhCP-A5 abrogates the MUC2 protective function by cleavage of the MUC2 C-terminus and that EhCP-A5 also plays an role in contact-dependent mucin hypersecretion during intestinal amebiasis [<xref rid="ppat.1005853.ref039" ref-type="bibr">39</xref>]. Correlation between CP activity and ALA formation was described for the non-pathogenic cell line HM-1:IMSS_A (CP activity, ~15 mU/mg) and the pathogenic cell line HM-1:IMSS_B (CP activity, ~110 mU/mg), as well as clones B2<sup>p</sup> (CP activity, ~120 mU/mg) and A1<sup>np</sup> (CP activity, ~15 mU/mg) [<xref rid="ppat.1005853.ref003" ref-type="bibr">3</xref>, <xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>]. However, determination of CP activities, especially in B-clones, did not support these observations. Prominent examples of this discrepancy are clones B1 and B12, which are non-pathogenic but have the highest CP activity of all the clones analysed (~150&#x02013;200 mU/mg). Substrate gel electrophoresis experiments indicated that these different levels of CP activity result from altered abundances of all major CPs rather than from changes of individual CPs. Such lack of correlation between CP activity levels and ALA formation was reported in only one other publication, where Montfort and colleagues also used pathogenic and non-pathogenic cultures of <italic>E</italic>. <italic>histolytica</italic> isolate HM-1:IMSS [<xref rid="ppat.1005853.ref021" ref-type="bibr">21</xref>]. However, the missing correlation between CP activity and ALA formation is not necessarily inconsistent with previous results. Therefore, it can&#x02019;t be excluded that a high CP activity alone is not sufficient to induce ALAs. Other factors may be involved that, in combination with the CPs, lead to ALA formation. Furthermore, it was recently shown, that the different CPs have different impact on ALA formation. It was shown that overexpression of <italic>ehcp-a5</italic>, one of the major expressed <italic>ehcps</italic>, but also of the very low expressed <italic>ehcps</italic>, <italic>ehcp-b8</italic>, <italic>-b9</italic>, and <italic>-c13</italic> restored the pathogenic phenotype of the non-pathogenic clone A1<sup>np</sup>, whereas overexpression of various other peptidase genes including the major expressed <italic>ehcp-a1</italic> and <italic>ehcp-a2</italic> had no effect on pathogenicity [<xref rid="ppat.1005853.ref003" ref-type="bibr">3</xref>]. In addition, in the present study the expression level of the genes under culture conditions were compared between the different clones. However it was recently shown, that the expression level of some <italic>ehcp</italic> genes (<italic>ehcp-a3</italic>, <italic>-a4</italic>, <italic>-a5</italic>, <italic>-a6</italic>, <italic>-a10</italic>, <italic>-b8</italic>, <italic>-b9</italic>, <italic>and -c13</italic>) increased during ALA formation [<xref rid="ppat.1005853.ref003" ref-type="bibr">3</xref>]. Therefore, it can be speculated, that the non-pathogenic amoebae lost their ability to regulate the expression of the peptidases under altered environmental conditions.</p><p>In addition to CP activity, other frequently used <italic>in vitro</italic> pathogenicity markers are erythrophagocytosis, haemolytic activity and cytopathic activity. In contrast with most reports that described a correlation between erythrophagocytosis and ALA formation [<xref rid="ppat.1005853.ref022" ref-type="bibr">22</xref>, <xref rid="ppat.1005853.ref040" ref-type="bibr">40</xref>&#x02013;<xref rid="ppat.1005853.ref043" ref-type="bibr">43</xref>], Monfort and colleagues and Tsutsumi and colleagues, as well as this study, did not confirm this correlation [<xref rid="ppat.1005853.ref021" ref-type="bibr">21</xref>, <xref rid="ppat.1005853.ref044" ref-type="bibr">44</xref>]. In the present study, non-pathogenic clone B8<sup>np</sup> showed the highest erythrophagocytosis rate, followed by clones A1<sup>np</sup> and B2<sup>p</sup>. Recently, a mechanism described as amoebic trogocytosis was identified, where amoebae ingest &#x0201c;bites&#x0201d; of host cells [<xref rid="ppat.1005853.ref045" ref-type="bibr">45</xref>, <xref rid="ppat.1005853.ref046" ref-type="bibr">46</xref>]. Interestingly, only living cells were ingested by trogocytosis, whereas dead cells were phagocytosed in total. So far, we have no hint if amoebic trogocytosis correlates with the different ability of clone A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup> to from ALAs. However, none of the molecules with known function in amoebic trogocytosis of erythrocytes were found to be differentially expressed in either of the three clones [<xref rid="ppat.1005853.ref045" ref-type="bibr">45</xref>].</p><p>Haemolytic activity has also been reported as related to pathogenicity [<xref rid="ppat.1005853.ref022" ref-type="bibr">22</xref>, <xref rid="ppat.1005853.ref047" ref-type="bibr">47</xref>]. However, similarly to what was described decades ago by Keller and colleagues [<xref rid="ppat.1005853.ref048" ref-type="bibr">48</xref>], we did not observe any correlation of this trait with virulence. We showed that non-pathogenic clone B8<sup>np</sup> was unable to lyse erythrocytes, while non-pathogenic clone A1<sup>np</sup> had a higher haemolytic activity than pathogenic clone B2<sup>p</sup>. Furthermore, it was recently shown that haemolytic activity of the non-pathogenic cell line HM-1:IMSS_A is significantly higher than that of the pathogenic cell line HM-1:IMSS_B [<xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>].</p><p>It is indisputable that cytopathogenicity is an important feature for <italic>E</italic>. <italic>histolytica</italic> pathogenicity [<xref rid="ppat.1005853.ref049" ref-type="bibr">49</xref>, <xref rid="ppat.1005853.ref050" ref-type="bibr">50</xref>]. However, to the best of our knowledge, no study has correlated cytopathogenicity with virulence. A comparison of the abilities of clones A1<sup>np</sup>, B2<sup>p</sup>, and B8<sup>np</sup> to disrupt a CHO cell monolayer showed that clone A1<sup>np</sup> had the highest cytopathic activity, whereas clone B8<sup>np</sup> had no cytopathic activity. Therefore, even when cytopathic activity was taken into consideration, no correlation with ALA formation could be found.</p><p>The non-pathogenic clone A1<sup>np</sup> exhibits a higher haemolytic and cytopathic activity in contrast to clone B8<sup>np</sup>, while the motility of clone B8<sup>np</sup> is higher compared to clone A1<sup>np</sup>. From these phenotypical observations we speculate that pathogenicity of the parasite might require i) the ability to destroy and ii) phagocytose host cells and iii) to exhibit a certain motility, parameters which we find to be combined in clone B2<sup>p</sup>. Finally we conclude that the ability of <italic>E</italic>. <italic>histolytica</italic> to destroy liver tissue involves complex processes, from both, the parasite and the host side [<xref rid="ppat.1005853.ref024" ref-type="bibr">24</xref>].</p><p>The genome of <italic>E</italic>. <italic>histolytica</italic> comprises ~8400 genes. Matching the transcriptomes of clones A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup> to one another revealed that only a minority of genes were differentially transcribed. Comparing the transcriptomes of non-pathogenic clone A1<sup>np</sup> and pathogenic clone B2<sup>p</sup> revealed 46 genes that were more highly expressed in clone A1<sup>np</sup> and 30 genes that were more highly expressed in clone B2<sup>p</sup> (&#x02265;3-fold). The expression of 60% [18/31] of the genes that were differentially expressed in mother cell lines HM-1:IMSS_A and HM-1:IMSS_B [<xref rid="ppat.1005853.ref012" ref-type="bibr">12</xref>] was also significantly different for clones A1<sup>np</sup> and B2<sup>p</sup>. These included genes encoding Rab family GTPases (EhRab7D, EHI_082070; EhRab7E, EHI_169280; EhRab 7G, EHI_187090), C2 domain-containing protein (EhC2-2, EHI_118130) and cell surface protease gp63 (EhMP8-2, EHI_042870). Comparison of the pathogenic clone B2<sup>p</sup> with the non-pathogenic clone B8<sup>np</sup>, both derived from pathogenic cell line HM-1:IMSS_B, revealed only 19 differentially expressed genes (&#x02265;3-fold). Of these, 12 were more highly expressed in clone B8<sup>np</sup> and seven were more highly expressed in clone B2<sup>p</sup>. Only six genes were regulated in the same manner in the two non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup> (EHI_026360, EHI_056490, EHI_039020, EHI_127670, EHI_144490 and EHI_144610).</p><p>Since the identified differentially expressed genes encode proteins of divergent function or hypothetical proteins, it is speculative whether these genes correlate with pathogenic amoeba phenotype. To clarify this issue, we generated overexpression transfectants for a set of candidate genes. Six genes up-regulated in clone A1<sup>np</sup>, six genes up-regulated in clone B8<sup>np</sup> and three genes up-regulated in clones A1<sup>np</sup> and B8<sup>np</sup>, in comparison with B2<sup>p</sup>, were overexpressed in B2<sup>p</sup>. Significant reduction in abscess size in comparison with the control was determined for 7/15 B2<sup>p</sup> transfectants. The respective overexpressed genes encoded two C2 domain proteins (EhC2-3, EHI_15290; EhC2-5, EHI_05980), cell surface protease gp63 (EhMP8-2, EHI_042870), two alcohol dehydrogenases (EHI_088020, EHI_160670) and two hypothetical proteins (EHI_075690, EHI_058920).</p><p>Within the <italic>E</italic>. <italic>histolytica</italic> genome, four genes (EHI_069320, EHI_118130, EHI_015290, EHI_059860) were identified as encoding C2 domain proteins that have 60&#x02013;75% identity. Three of these were more highly expressed in clone A1<sup>np</sup> compared with clone B2<sup>p</sup>, and for all three the respective B2<sup>p</sup> transfectants were generated. Overexpression of EHI_015290 (EhC2-3) and EHI_059860 (EhC2-5) significantly reduced pathogenicity of clone B2<sup>p</sup>. In general, C2 domains are involved in targeting proteins to cell membranes. Thus far, only one (EHI_069320, EhC2-1) of the C2 domain proteins has been characterised. It mediates anchoring of the transcription factor URE3-BP to the amoebic plasma membrane [<xref rid="ppat.1005853.ref051" ref-type="bibr">51</xref>].</p><p>Two cell surface protease gp63 homologues (EHI_200230, EhMP8-1; EHI_042870, EhMP8-2) are encoded in the <italic>E</italic>. <italic>histolytica</italic> genome. EhMP8-2 was more highly expressed in clone A1<sup>np</sup> in comparison with clone B2<sup>p</sup>. This was also true for the two cell lines HM-1:IMSS_A and HM-1:IMSS_B [<xref rid="ppat.1005853.ref012" ref-type="bibr">12</xref>]. However, no differential expression was observed for EhMP8-1. Both metalloproteases belong to the M8 family zinc metalloproteases with homology to leishmanolysin, a protein essential for virulence of <italic>Leishmania</italic> [<xref rid="ppat.1005853.ref052" ref-type="bibr">52</xref>, <xref rid="ppat.1005853.ref053" ref-type="bibr">53</xref>]. They contain a zinc-binding HEXXH catalytic site motif and a putative transmembrane domain, and have 34% identity with each other. EhMP8-1 is localised on the trophozoite surface, and further characterisation revealed involvement in adherence, mobility, cytopathogenic activity and phagocytosis [<xref rid="ppat.1005853.ref054" ref-type="bibr">54</xref>]. There is no indication that EhMP8-2 exhibits similar functions, since its expression levels in different clones did not correlate with cytopathogenic activity and phagocytosis.</p><p>The expression of EHI_075690 was five times higher in A1<sup>np</sup> than in B2<sup>p</sup>. The gene EHI_075690 encodes a 218-amino acid hypothetical protein. <italic>In silico</italic> analysis revealed that the protein consists of four transmembrane domains with homology to tetraspanin family proteins. Until now, six tetraspanins were identified in the <italic>E</italic>. <italic>histolytica</italic> genome; however, their function is mostly unknown [<xref rid="ppat.1005853.ref055" ref-type="bibr">55</xref>]. In general, tetraspanins are known to be involved in cell proliferation, adhesion, signalling and migration [<xref rid="ppat.1005853.ref056" ref-type="bibr">56</xref>]. Recently, it was shown that the tetraspanin TvTSP8 of <italic>Trichomonas vaginalis</italic> is involved in parasite-parasite communication [<xref rid="ppat.1005853.ref057" ref-type="bibr">57</xref>].</p><p>EHI_058920 was more highly expressed in clone B8<sup>np</sup> in comparison with clone B2<sup>p</sup>, and overexpression reduced the pathogenicity of clone B2<sup>p</sup>. The gene encodes a protein of 316 amino acids. No homologues in other organisms and no conserved domains were identified within the protein.</p><p>EHI_088020 and EHI_160670, both more highly expressed in clone B8<sup>np</sup> in comparison with clone B2<sup>p</sup>, encode alcohol dehydrogenases with the highest homology to Fe-dependent dehydrogenases of Gram-negative obligatorily anaerobic prokaryotes. Therefore, it may be assumed that they were incorporated into the amoebal genome by lateral gene transfer. As mentioned above, <italic>in silico</italic> analyses indicated that amino acid sequences of proteins encoded by EHI_088020 and EHI_160670 are identical; however, the first 160 amino acids of EHI_088020 are missing from the EHI_160670 sequence. Since EHI_160670 is located at the 5&#x02032;-end of the published contig DS571485, this &#x02018;deletion&#x02019; may be explained by a not-fully annotated status of the <italic>E</italic>. <italic>histolytica</italic> genome (AmoebaDB, <ext-link ext-link-type="uri" xlink:href="http://amoebadb.org/amoeba/">http://amoebadb.org/amoeba/</ext-link>). However, we were unable to identify the sequence upstream of EHI_160670. Nevertheless, ectopic expression of the full-length or truncated gene affected abscess formation, as it significantly reduced the pathogenicity of clone B2<sup>p</sup>. At least ten genes encoding alcohol dehydrogenases are found in the genome of <italic>E</italic>. <italic>histolytica</italic>. Two of them show 79% (EHI_192470) and 70% (EHI_198760) amino acid sequence identity with EHI_088020. The expression levels of both genes were similar in different clones. Interestingly, EHI_198760 (EhADH3) was described to be present in lower amounts in the non-pathogenic isolate Rahman, as well as in <italic>E</italic>. <italic>dispar</italic> in comparison to E. histolytica HM-1:IMSS [<xref rid="ppat.1005853.ref010" ref-type="bibr">10</xref>, <xref rid="ppat.1005853.ref058" ref-type="bibr">58</xref>]. However, no correlation between EhAH3 amount and pathogenicity was observed [<xref rid="ppat.1005853.ref058" ref-type="bibr">58</xref>].</p><p>Interestingly, none of the three genes (EHI_026360, EHI_056490, EHI_039020) up-regulated in the two non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup> vs. pathogenic clone B2<sup>p</sup> affected ALA formation during infection with their overexpressing B2<sup>p</sup> transfectants.</p><p>Of the genes that were more highly expressed in clone B2<sup>p</sup> in comparison with clones A1<sup>np</sup> or B8<sup>np</sup>, the only one impacting ALA formation when overexpressed was EHI_127670. EHI_127670 was one of the genes that was more highly expressed in clone B2<sup>p</sup> than in the two non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup>. Transfectants of either clone ectopically expressing this gene were able to induce ALA formation. However, since the pathogenic phenotype was only observed in 4/9 animals infected with A1<sup>np</sup>-EHI_127670 transfectants and 6/9 animals infected with B8<sup>np</sup>-EHI_127670 transfectants, these results were not statistically significant. Interestingly, if the results of both non-pathogenic clones overexpressing EHI_12760 were summarised the effect on ALA formation became significant. EHI_127670 encodes a putative protein of 111 amino acids. No homologues and no conserved domains within the protein were identified.</p><p>In this study we analysed the influence on ALA formation for 20 out of the 89 differentially expressed genes identified. However, it was not possible to overexpress 4 <italic>rab</italic> protein encoding genes (EHI_082070/<italic>ehrab7d</italic>, EHI_169280/<italic>ehrab7e</italic>, EHI_187090/<italic>ehrab7g</italic>, EHI164900), which are highly expressed in clone A1<sup>np</sup> and very low expressed in clone B2<sup>p</sup>. This differential expression was also observed comparing the non-clonal cell lines A and B [<xref rid="ppat.1005853.ref012" ref-type="bibr">12</xref>]. Rab GTPases are essential for the regulation of vesicular trafficking in the endocytic and exocytic/secretory pathways of eukaryotic cells [<xref rid="ppat.1005853.ref059" ref-type="bibr">59</xref>]. The genome of <italic>E</italic>. <italic>histolytica</italic> contains more than 90 <italic>rab</italic> genes, including nine of the Rab7 isotype. Therefore, <italic>E</italic>. <italic>histolytica</italic> seems to be an organism with extremely diverse and complex Rab functions [<xref rid="ppat.1005853.ref060" ref-type="bibr">60</xref>, <xref rid="ppat.1005853.ref061" ref-type="bibr">61</xref>]. One of the Rab7 isotypes, namely EhRab7A, is involved in transport of CPs to phagosomes and in recycling of a CP receptor from the phagosomes to the <italic>trans</italic>-Golgi network [<xref rid="ppat.1005853.ref062" ref-type="bibr">62</xref>&#x02013;<xref rid="ppat.1005853.ref064" ref-type="bibr">64</xref>]. EhRab7A and EhRab7B are involved in lysosome biogenesis [<xref rid="ppat.1005853.ref061" ref-type="bibr">61</xref>]. There is additional evidence that all EhRab7 isotypes are sequentially and coordinately involved in phagosome biogenesis [<xref rid="ppat.1005853.ref061" ref-type="bibr">61</xref>]. However, so far it remains elusive whether the differential expression of the 4 <italic>rab</italic> genes indeed influences the ALA formation.</p><sec id="sec011"><title>Conclusion</title><p>In this study, no correlation was found between the ability of <italic>E</italic>. <italic>histolytica</italic> clones to produce amoebic liver abscesses and their cysteine protease, haemolytic, erythrophagocytosis, or cytopathic activities, or their sizes or growth characteristics. However, the clones showed different expression profiles. We conclude that different mechanisms result in the loss of <italic>E</italic>. <italic>histolytica</italic> pathogenicity, because only a few genes were found to be differentially regulated in the same way when either of the two non-pathogenic clones A1<sup>np</sup> and B8<sup>np</sup> were compared with the pathogenic clone B2<sup>p</sup>. However, overexpression of seven different genes, encoding a metallopeptidase, C2 domain proteins, alcohol dehydrogenases, and hypothetical proteins in the pathogenic clone B2<sup>p</sup> correlated with reduced ability of <italic>E</italic>. <italic>histolytica</italic> to produce amoebic liver abscesses. Only one gene was identified whose overexpression transformed a non-pathogenic phenotype into a pathogenic one.</p></sec></sec><sec sec-type="materials|methods" id="sec012"><title>Methods</title><sec id="sec013"><title>Ethics statement</title><p>Animal experiments were carried out in accordance with the guidelines from the German National Board for Laboratory Animals and ARRIVE guidelines (<ext-link ext-link-type="uri" xlink:href="https://www.nc3rs.org.uk/arrive-guidelines">https://www.nc3rs.org.uk/arrive-guidelines</ext-link>) and approved by the review board of the State of Hamburg, Germany (Ministry of Health and Consumer Protection/Beh&#x000f6;rde f&#x000fc;r Gesundheit und Verbraucherschutz&#x02014;ethical permits 145/13, 20.01.2014)</p></sec><sec id="sec014"><title><italic>E</italic>. <italic>histolytica</italic> cell culture</title><p><italic>E</italic>. <italic>histolytica</italic> trophozoites were cultured axenically in TYI-S-33 medium in plastic tissue culture flasks [<xref rid="ppat.1005853.ref065" ref-type="bibr">65</xref>]. <italic>E</italic>. <italic>histolytica</italic> cell lines HM-1:IMSS-A and HM-1:IMSS-B were derived from the isolate HM-1:IMSS and both were originally obtained from the American Type Culture Collection (ATCC) under the catalogue number 30459[<xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>]. HM-1:IMSS was originally isolated from a colonic biopsy of rectal ulcer from an adult male patient with amoebic dysentry in 1967 (Mexico City, Mexico). The monoxenic cultured HM-1:IMSS isolate was passed from Margarita de la Torre to Louis S. Diamond who adapted it to axenic cultivation. Thereafter, this axenically cultivated HM-1:IMSS isolate was transferred to the ATCC library. Cell line A was sent to us in 2001 by Barbara Mann (Charlottesville, University of Virginia), as a batch of cells from the same culture that was used for DNA preparation to sequence the <italic>E</italic>. <italic>histolytica</italic> genome [<xref rid="ppat.1005853.ref066" ref-type="bibr">66</xref>]. The pathogenic cell line B was obtained directly from ATCC in 1991. Since then, the ability of cell line B to induce liver pathology remained stable.</p><p>Both cell lines were cloned by limited dilution. For this, a dilution of 120 amoebae/24 ml TYI-S-33 medium was prepared and 200 &#x003bc;l of this dilution was added to each well of a 96-well plate. The presence of only one amoebae/well was analysed microscopically and the trophozoites were cultivated under anaerobic conditions using Anaerocult (Merck) for one week. Afterwards the clones were transferred for further cultivation to tissue culture flasks.</p><p>For individual experiments, 1 &#x000d7; 10<sup>6</sup> trophozoites were cultivated for 24 h in 75 mL culture flasks. Subsequently, after chilling on ice for 5 min, trophozoites were harvested by sedimentation at 430 &#x000d7; <italic>g</italic> at 4&#x000b0;C for 5 min. The resulting cell pellets were washed twice either in phosphate-buffered saline (PBS; 6.7 mM NaHPO<sub>4</sub>, 3.3 mM NaH<sub>2</sub>PO<sub>4</sub>, 140 mM NaCl, pH 7.2) or in incomplete TYI-S-33 medium (medium without serum). To prepare amoeba extracts, cells were lysed over four freeze-thaw cycles in CO<sub>2</sub>/ethanol and sedimented by centrifugation (9000 &#x000d7; <italic>g</italic> at 4&#x000b0;C for 15 min).</p></sec><sec id="sec015"><title>ALA formation in gerbils and mice</title><p>Animal infections were performed with 10- to 12-week-old female gerbils obtained from JANVIER LABS (Saint Berthevin Cedex 53941 France) or with 10- to 12-week-old C57BL/6 male mice bred in the animal facility of the Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. All animals were maintained in a specific pathogen-free environment. Animal experiments were approved by the review board of the State of Hamburg, Germany (Ministry of Health and Consumer Protection/Beh&#x000f6;rde f&#x000fc;r Gesundheit und Verbraucherschutz, (145/13, 20.01.2014) and conducted in accordance with institutional and ARRIVE guidelines (<ext-link ext-link-type="uri" xlink:href="https://www.nc3rs.org.uk/arrive-guidelines">https://www.nc3rs.org.uk/arrive-guidelines</ext-link>).</p><p>For gerbil infections, 1 &#x000d7; 10<sup>6</sup> trophozoites in 50 &#x003bc;L of incomplete TYI-S-33 medium (without serum) were injected into the left liver lobe, as described previously [<xref rid="ppat.1005853.ref067" ref-type="bibr">67</xref>]. For mice infection experiments, 1.25 &#x000d7; 10<sup>5</sup> trophozoites in 25 &#x003bc;L of incomplete TYI-S-33 medium were injected into the liver, as described by Lotter and colleagues [<xref rid="ppat.1005853.ref023" ref-type="bibr">23</xref>].</p><p>To analyse ALA formation of the various amoeba clones, gerbils were sacrificed at 7 days post infection and the extent of the abscessed liver area was measured manually using a caliper and determined as size in mm<sup>2</sup>. For each <italic>E</italic>. <italic>histolytica</italic> clone, ALA formation was analysed in at least four animals. Significance (<italic>p</italic>-values) was established using the Mann-Whitney <italic>U</italic> test.</p><p>MRI was performed to analyse the time course of ALA formation using a small animal 7 Tesla MR scanner (ClinScan, Bruker Biospin GmbH, Ettlingen, Germany). For these experiments, gerbil and mouse livers were imaged <italic>in vivo</italic> on days 3, 5, 7 and 10 after intrahepatic injection of <italic>E</italic>. <italic>histolytica</italic>. Anaesthesia was performed as described by Ernst and colleagues [<xref rid="ppat.1005853.ref068" ref-type="bibr">68</xref>]. Images were acquired using T2-weighted fast spin echo (T2w FSE) sequences for high-resolution anatomical reference. Total abscess volume was calculated by measuring the region of interest (ROI) in each abscess-containing slice, using transversal sections of the abdomen and the OsiriX Imaging Software DICOM Viewer (Open-source version 32-bit 4.1.1). Significance (<italic>p-</italic>values) was established using an unpaired t test.</p></sec><sec id="sec016"><title>RNA extraction and qRT-PCR</title><p><italic>E</italic>. <italic>histolytica</italic> trophozoites (1 &#x000d7; 10<sup>6</sup>) were cultivated in 75 mL culture flasks for 24 h. The cells were harvested after chilling on ice for 5 min and sedimented at 200 &#x000d7; <italic>g</italic> for 5 min at 4&#x000b0;C. Cell pellets were washed twice with PBS. To isolate total RNA, trophozoites were treated with TRIzol reagent (Thermo Fisher Scientific, Schwerte, Germany) following the manufacturer&#x02019;s instructions. Extracted RNA was further purified using the RNeasy mini kit (Qiagen, Hilden, Germany) but without &#x003b2;-mercaptoethanol in buffer RLT, and DNA was digested with DNase I (Qiagen, Hilden, Germany). Total RNA for transcriptomics analyses was purified using the <italic>mir</italic>Vana miRNA isolation kit (Ambion-Thermo Fisher Scientific, Schwerte, Germany), according to the manufacturer&#x02019;s instructions.</p><p>cDNA synthesis was obtained using the SuperScript III Reverse Transcriptase system (Thermo Fisher Scientific, Schwerte, Germany). Briefly, RNase-free and DNase-treated total RNA (1 &#x003bc;g in a 20 &#x003bc;L final volume) was mixed with 5 &#x000d7; First-Strand buffer, 1 mM dNTPs, 500 nM OdT-T71 (5&#x02032;-GAG AGA GGA TCC AAG TAC TAA TAC GAC TCA CTA TAG GGA GAT<sub>24</sub>), 2 mM DTT, 0.5 mM MgCl<sub>2</sub>, 40 U RNaseOut (Thermo Fisher Scientific, Schwerte, Germany) and SuperScript III (200 U/&#x003bc;L). cDNA was synthesised for 1 h at 42&#x000b0;C.</p><p>For qRT-PCR experiments, sense and antisense primers were designed to amplify 100&#x02013;120 bp fragments of the respective genes (<xref ref-type="supplementary-material" rid="ppat.1005853.s008">S8</xref> and <xref ref-type="supplementary-material" rid="ppat.1005853.s009">S9</xref> Tables). Quantitative amplifications were performed in Rotor-Gene PCR apparatus (Qiagen, Hilden, Germany) using RealMasterMix SYBR ROX Kit (5PRIME, Hilden, Germany). cDNA (1 &#x003bc;L) was mixed with 2.5 &#x000d7; RealMasterMix/20 &#x000d7; SYBR and 5 pmol/&#x003bc;L appropriate sense and antisense primers, to a final 20 &#x003bc;L volume. Amplification conditions were as follows: 40 cycles of 95&#x000b0;C for 15 s, 58&#x000b0;C for 20 s and 68&#x000b0;C for 20 s, and an adjacent melting step (67&#x02013;95&#x000b0;C). Two biological replicates were analysed in duplicate. Relative differences in gene expression were calculated using the 2<sup>-&#x00394;&#x00394;CT</sup> method with Rotor-Gene software [<xref rid="ppat.1005853.ref069" ref-type="bibr">69</xref>]. Depending on the experiment, clone A1<sup>np</sup>, clone B2<sup>p</sup>, or clone B8<sup>np</sup> was used as the calibrator (= 1), and actin was used as the house-keeping gene for normalisation.</p></sec><sec id="sec017"><title>Transcriptome analyses and bioinformatics</title><p>RNA for RNA-Seq library preparation was purified as described above. RNA quantity and quality were evaluated spectrophotometrically (NanoDrop 2000, Thermo Fisher Scientific, Schwerte, Germany) and with an Agilent 2100 Bioanalyzer with RNA 6000 Pico Assays kit (Agilent Technologies, Waldbronn, Germany).</p><p>Samples were Turbo DNase-treated using TURBO DNA-free Kit (Ambion-Thermo Fisher Scientific, Schwerte, Germany). After quality control, rRNA was depleted using RiboZero Magnetic Gold kit (Human/Mouse/Rat; Epicentre-Illumina, Munich, Germany) and Agencourt RNAClean XP kit (Beckmann Coulter, Krefeld, Germany), according to the manufacturers&#x02019; protocol. RNA-Seq libraries were then generated using ScriptSeq v2 kit (Epicentre-Illumina, Munich, Germany) according to the manufacturer&#x02019;s instructions. Each library was indexed with Illumina-compatible barcodes to allow multiplexing. The individual libraries were assessed using Qubit dsDNA high sensitivity kit and Bioanalyzer DNA HS chips to ascertain the concentration (4 nM) and fragment size distribution, respectively, prior to library multiplexing. Libraries were denatured and diluted to final concentration of 8 pM for sequencing on the MiSeq platform following the manufacturer&#x02019;s instructions. Reads were aligned to <italic>E</italic>. <italic>histolytica</italic> transcriptome (AmoebaDB 28, released 30 March 2016) using Bowtie 2 version 2.2.3 [<xref rid="ppat.1005853.ref070" ref-type="bibr">70</xref>] and differential expression was analysed using DESeq [<xref rid="ppat.1005853.ref071" ref-type="bibr">71</xref>] version 1.18.</p></sec><sec id="sec018"><title>Determination of sizes, growth rates and motility of <italic>E</italic>. <italic>histolytica</italic> clone A1<sup>np</sup>, B2<sup>p</sup> and B8<sup>np</sup></title><p>To determine amoeba size, the circumference of 80 trophozoites of each clone was measured using a BZ9000 Keyence microscope (Keyence, Neu-Isenburg, Germany). To determine growth rate, 500 trophozoites of each clone were seeded into a 24-well plate and the cells were counted every 24 h over 72 h. The growth rate was determined three times in triplicate for each clone. The movement of the amoebae was directly filmed over a time period of 10 min using Evos FL Auto microscope from Life Technologies. A picture was taken every 5 sec. The movement of 80 amoebae/ clone was analysed manually using ImageJ version 2.0.0-rc-43/1.51d with plugins for manual tracking and chemotaxis. Significance (<italic>p-</italic>values) was established using the Mann-Whitney <italic>U</italic> test.</p></sec><sec id="sec019"><title>Cysteine peptidase assay</title><p>CP activity was measured using the synthetic peptide Z-Arg-Arg-pNA (Bachem, Bubendorf, Switzerland) as substrate [<xref rid="ppat.1005853.ref072" ref-type="bibr">72</xref>]. One unit of enzymatic activity is defined as the amount of protein that catalyses the generation of 1 &#x003bc;moL <italic>p</italic>-nitroaniline per min.</p></sec><sec id="sec020"><title>Substrate gel electrophoresis</title><p>Substrate gel electrophoresis was performed as described previously [<xref rid="ppat.1005853.ref073" ref-type="bibr">73</xref>]. Briefly, amoebic extract (2 &#x003bc;g) was incubated in Laemmli buffer with 20 mM DTT, for 5 min at 37&#x000b0;C. For the substrate gel, 12% SDS-polyacrylamide gel was co-polymerised with 0.1% gelatine. After protein separation and incubation in buffer A (2.5% Triton X-100; 1 h) and buffer B (100 mM sodium acetate, pH 4.5, 1% Triton X-100, 20 mM DTT; 3 h), at 37&#x000b0;C, the gel was stained with Coomassie blue.</p></sec><sec id="sec021"><title>Erythrophagocytosis assay</title><p>Erythrophagocytosis assay was performed as described by Biller and colleagues [<xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>]. Human 0+ erythrocytes were provided by the blood bank of the University Medical Center Hamburg-Eppendorf (UKE)&#x02013;Transfusion Medicine&#x02013;Germany. Human erythrocytes and trophozoites were washed twice with serum-free TYI-S-33 medium. Erythrocytes and amoebae were mixed at a 1000:1 ratio (2 &#x000d7; 10<sup>8</sup> erythrocytes, 2 &#x000d7; 10<sup>5</sup> amoebae), to a final volume of 400 &#x003bc;L, in serum-free TYI-S-33 medium and incubated in parallel at 37&#x000b0;C for 30 min. To stop phagocytosis and lyse non-phagocytosed erythrocytes, 1 mL of distilled water was added, twice. Trophozoites were washed twice with PBS. Average numbers of ingested erythrocytes were quantified by measuring the absorbance at 397 nm after trophozoite lysis in 90% formic acid. The experiment was performed three times in triplicate. Significance (<italic>p</italic>-values) was established using the Mann-Whitney <italic>U</italic> test.</p></sec><sec id="sec022"><title>Haemolytic activity assay</title><p>Haemolytic activity assay was performed as described by Biller and colleagues [<xref rid="ppat.1005853.ref011" ref-type="bibr">11</xref>]. Human erythrocytes and trophozoites were washed three times with PBS. The assay was performed by mixing trophozoites and erythrocytes in a 1:2000 ratio (2 &#x000d7; 10<sup>5</sup> amoebae with 4 &#x000d7; 10<sup>8</sup> erythrocytes per mL of PBS), followed by incubation for 1 h at 37&#x000b0;C. After incubation, the cells were sedimented for 1 min at 2000 &#x000d7; <italic>g</italic>. Haemoglobin released into the supernatant was measured at 570 nm in a spectrophotometer. Separately incubated erythrocytes and trophozoites were used as negative controls. To determine 100% haemoglobin release, 4 &#x000d7; 10<sup>8</sup> erythrocytes were lysed in 1 mL of water. The experiment was performed three times in triplicate. Significance (<italic>p</italic>-values) was established using the Mann-Whitney <italic>U</italic> test.</p></sec><sec id="sec023"><title>Cytopathic activity</title><p>Interaction of trophozoites and Chinese hamster ovarian (CHO) cells was determined by a modified method of Bracha and Mirelman [<xref rid="ppat.1005853.ref074" ref-type="bibr">74</xref>]. CHO cells defective in glycosaminoglycan biosynthesis (CHO-745; American Type Culture Collection No. CRL-2242) were used. CHO cells (1 &#x000d7; 10<sup>5</sup> per well) were grown for 24 h in 24-well plates in Ham&#x02019;s F12 (with <sc>l</sc>-Glutamine) medium supplemented with 10% fetal calf serum (FCS) and penicillin-streptomycin. After washing the CHO cells with preheated (37&#x000b0;C) Ham&#x02019;s medium, 500 &#x003bc;L of Ham&#x02019;s medium was added. <italic>E</italic>. <italic>histolytica</italic> trophozoites (1 &#x000d7; 10<sup>5</sup>) were washed twice with serum-free TYI-S-33 medium, resuspended in 500 &#x003bc;L of ABS-free TYI-S-33 and added to the CHO cells. The mixture was incubated for 20 min at 37&#x000b0;C under 5% CO<sub>2</sub>. Cells were washed with 1 mL of ice-cold PBS and treated with 0.5 mL of 4% paraformaldehyde in PBS for 2 min. After another PBS wash, the cells were stained with 500 &#x003bc;L of 0.1% methylene blue for 2 min. Finally, the cells were washed with 0.01% methylene blue and PBS. Cells were lysed with 1 mL of 0.1 M HCl for 30 min at 37&#x000b0;C. Samples were photometrically analysed at 660 nm. As a control, methylene blue concentration was determined for CHO cells that had not been co-cultivated with trophozoites (i.e., no destruction of cell monolayer). Experiments were performed three times in sextuplicate. Significance (<italic>p</italic>-values) was established using the Mann-Whitney <italic>U</italic> test.</p></sec><sec id="sec024"><title>Expression constructs</title><p>All plasmids used for <italic>E</italic>. <italic>histolytica</italic> trophozoite transfections are derivatives of the expression vector pEhNEO/CAT (pNC) [<xref rid="ppat.1005853.ref075" ref-type="bibr">75</xref>, <xref rid="ppat.1005853.ref076" ref-type="bibr">76</xref>]. Genes of interest were amplified by PCR using genomic <italic>E</italic>. <italic>histolytica</italic> DNA as a template, cloned into TOPO TA vector, sequenced and cloned into pNC using <italic>Kpn</italic>I and <italic>Bam</italic>HI restriction sites (<xref ref-type="supplementary-material" rid="ppat.1005853.s009">S9 Table</xref>). For overexpression, coding sequences of the genes of interest were flanked by 485 bp 5&#x02032;-untranslated sequence of the <italic>E</italic>. <italic>histolytica</italic> lectin gene and 600 bp 3&#x02032;-untranslated region of the actin gene. Neomycin phosphotransferase was used as a selectable marker.</p><p>Transfections were performed by electroporation as described previously [<xref rid="ppat.1005853.ref076" ref-type="bibr">76</xref>]. Two days post transfection, cells were transferred to a selection medium containing 10 &#x003bc;g/mL G-418 sulphate, for approximately 2 weeks. Subsequently, the cells were cloned by a limited dilution method and cultivated in the presence of 20 &#x003bc;g/mL G418. Successful overexpression of at least four clones was checked by qRT-PCR. For infection experiments, trophozoites were cultivated for 24 h in the absence of G418.</p></sec></sec><sec sec-type="supplementary-material" id="sec025"><title>Supporting Information</title><supplementary-material content-type="local-data" id="ppat.1005853.s001"><label>S1 Table</label><caption><title>Summary of <italic>p</italic>-values.</title><p>(DOC)</p></caption><media xlink:href="ppat.1005853.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005853.s002"><label>S2 Table</label><caption><title>Comparison of the transcriptomes of clone A1<sup>np</sup> and clone B2<sup>p</sup>.</title><p>(XLS)</p></caption><media xlink:href="ppat.1005853.s002.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005853.s003"><label>S3 Table</label><caption><title>Comparison of the transcriptomes of clone B8<sup>np</sup> and clone B2<sup>p</sup>.</title><p>(XLS)</p></caption><media xlink:href="ppat.1005853.s003.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005853.s004"><label>S4 Table</label><caption><title>Characteristics of the proteins encoded by the genes found to be differentially expressed between clone A1<sup>np</sup> and clone B2<sup>p</sup> and/or clone B8<sup>np</sup> and clone B2<sup>p</sup>.</title><p>(DOC)</p></caption><media xlink:href="ppat.1005853.s004.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005853.s005"><label>S5 Table</label><caption><title>Relative expression of overexpressing genes in clone B2<sup>p</sup> transfectants that originally showed higher expression in clone A1<sup>np(a)</sup> and/or B8<sup>np(b)</sup> than in clone B2<sup>p</sup>.</title><p>(DOC)</p></caption><media xlink:href="ppat.1005853.s005.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005853.s006"><label>S6 Table</label><caption><title>Relative expression of overexpressing genes in clone A1<sup>np</sup> transfectants that originally showed higher expression in clone B2<sup>p</sup> than in clone A1<sup>np</sup>.</title><p>(DOC)</p></caption><media xlink:href="ppat.1005853.s006.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005853.s007"><label>S7 Table</label><caption><title>Relative expression of overexpressing genes in clone B8<sup>np</sup> transfectants that originally showed higher expressed in clone B2<sup>p</sup> than in clone B8<sup>np</sup>.</title><p>(DOC)</p></caption><media xlink:href="ppat.1005853.s007.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005853.s008"><label>S8 Table</label><caption><title>Oligonucleotides used for verification of transcriptome results using qPCR.</title><p>(DOCX)</p></caption><media xlink:href="ppat.1005853.s008.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005853.s009"><label>S9 Table</label><caption><title>Oligonucleotides for gene amplification and for the analysis of overexpression in transfectants using qPCR.</title><p>(DOCX)</p></caption><media xlink:href="ppat.1005853.s009.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank J&#x000fc;rgen Sievertsen and Christa Ehmen for technical assistance.</p></ack><ref-list><title>References</title><ref id="ppat.1005853.ref001"><label>1</label><mixed-citation publication-type="book"><name><surname>Wertheim</surname><given-names>HFL</given-names></name>, <name><surname>Horby</surname><given-names>P</given-names></name>, <name><surname>Woodall</surname><given-names>JP</given-names></name>. <chapter-title>Disease: Amebiasis, Entamoeba histolytica</chapter-title> In: <source>Atlas of human infectios diseases</source>. <year>2012</year>; (<publisher-name>Wiley-Blackwell</publisher-name>):<fpage>126</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="ppat.1005853.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Blessmann</surname><given-names>J</given-names></name>, <name><surname>Ali</surname><given-names>IK</given-names></name>, <name><surname>Nu</surname><given-names>PA</given-names></name>, <name><surname>Dinh</surname><given-names>BT</given-names></name>, <name><surname>Viet</surname><given-names>TQ</given-names></name>, <name><surname>Van</surname><given-names>AL</given-names></name>, <etal>et al</etal>
<article-title>Longitudinal study of intestinal Entamoeba histolytica infections in asymptomatic adult carriers</article-title>. <source>J Clin Microbiol</source>. <year>2003</year>; <volume>41</volume>(<issue>10</issue>):<fpage>4745</fpage>&#x02013;<lpage>50</lpage>. .<?supplied-pmid 14532214?><pub-id pub-id-type="pmid">14532214</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Matthiesen</surname><given-names>J</given-names></name>, <name><surname>Bar</surname><given-names>AK</given-names></name>, <name><surname>Bartels</surname><given-names>AK</given-names></name>, <name><surname>Marien</surname><given-names>D</given-names></name>, <name><surname>Ofori</surname><given-names>S</given-names></name>, <name><surname>Biller</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Overexpression of specific cysteine peptidases confers pathogenicity to a nonpathogenic Entamoeba histolytica clone</article-title>. <source>MBio</source>. <year>2013</year>; <volume>4</volume>(<issue>2</issue>):<fpage>e00072</fpage>&#x02013;<lpage>13</lpage>. Epub 2013/03/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/mBio.00072-13">10.1128/mBio.00072-13</ext-link></comment> ; PubMed Central PMCID: PMC3604762.<?supplied-pmid 23532975?><pub-id pub-id-type="pmid">23532975</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Bracha</surname><given-names>R</given-names></name>, <name><surname>Nuchamowitz</surname><given-names>Y</given-names></name>, <name><surname>Leippe</surname><given-names>M</given-names></name>, <name><surname>Mirelman</surname><given-names>D</given-names></name>. <article-title>Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence</article-title>. <source>Mol Microbiol</source>. <year>1999</year>; <volume>34</volume>(<issue>3</issue>):<fpage>463</fpage>&#x02013;<lpage>72</lpage>. <?supplied-pmid 10564488?><pub-id pub-id-type="pmid">10564488</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Bracha</surname><given-names>R</given-names></name>, <name><surname>Nuchamowitz</surname><given-names>Y</given-names></name>, <name><surname>Mirelman</surname><given-names>D</given-names></name>. <article-title>Transcriptional silencing of an amoebapore gene in Entamoeba histolytica: molecular analysis and effect on pathogenicity</article-title>. <source>Eukaryot Cell</source>. <year>2003</year>; <volume>2</volume>(<issue>2</issue>):<fpage>295</fpage>&#x02013;<lpage>305</lpage>. .<?supplied-pmid 12684379?><pub-id pub-id-type="pmid">12684379</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Ankri</surname><given-names>S</given-names></name>, <name><surname>Stolarsky</surname><given-names>T</given-names></name>, <name><surname>Bracha</surname><given-names>R</given-names></name>, <name><surname>Padilla-Vaca</surname><given-names>F</given-names></name>, <name><surname>Mirelman</surname><given-names>D</given-names></name>. <article-title>Antisense inhibition of expression of cysteine proteinases affects <italic>Entamoeba histolytica</italic>-induced formation of liver abscess in hamsters</article-title>. <source>Infect Immun</source>. <year>1999</year>; <volume>67</volume>(<issue>1</issue>):<fpage>421</fpage>&#x02013;<lpage>2</lpage>. <?supplied-pmid 9864246?><pub-id pub-id-type="pmid">9864246</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>MacFarlane</surname><given-names>RC</given-names></name>, <name><surname>Singh</surname><given-names>U</given-names></name>. <article-title>Identification of differentially expressed genes in virulent and nonvirulent Entamoeba species: potential implications for amebic pathogenesis</article-title>. <source>Infect Immun</source>. <year>2006</year>; <volume>74</volume>(<issue>1</issue>):<fpage>340</fpage>&#x02013;<lpage>51</lpage>. .<?supplied-pmid 16368989?><pub-id pub-id-type="pmid">16368989</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>PH</given-names></name>, <name><surname>Schulze</surname><given-names>J</given-names></name>, <name><surname>Stanley</surname><given-names>SL</given-names><suffix>Jr.</suffix></name>
<article-title>Transcriptomic comparison of two Entamoeba histolytica strains with defined virulence phenotypes identifies new virulence factor candidates and key differences in the expression patterns of cysteine proteases, lectin light chains, and calmodulin</article-title>. <source>Mol Biochem Parasitol</source>. <year>2007</year>; <volume>151</volume>(<issue>1</issue>):<fpage>118</fpage>&#x02013;<lpage>28</lpage>. .<?supplied-pmid 17141337?><pub-id pub-id-type="pmid">17141337</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Ehrenkaufer</surname><given-names>GM</given-names></name>, <name><surname>Haque</surname><given-names>R</given-names></name>, <name><surname>Hackney</surname><given-names>JA</given-names></name>, <name><surname>Eichinger</surname><given-names>DJ</given-names></name>, <name><surname>Singh</surname><given-names>U</given-names></name>. <article-title>Identification of developmentally regulated genes in Entamoeba histolytica: insights into mechanisms of stage conversion in a protozoan parasite</article-title>. <source>Cell Microbiol</source>. <year>2007</year>; <volume>9</volume>(<issue>6</issue>):<fpage>1426</fpage>&#x02013;<lpage>44</lpage>. .<?supplied-pmid 17250591?><pub-id pub-id-type="pmid">17250591</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>PH</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Guo</surname><given-names>J</given-names></name>, <name><surname>Townsend</surname><given-names>RR</given-names></name>, <name><surname>Stanley</surname><given-names>SL</given-names><suffix>Jr</suffix></name>. <article-title>Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence</article-title>. <source>Mol Microbiol</source>. <year>2006</year>; <volume>61</volume>(<issue>6</issue>):<fpage>1523</fpage>&#x02013;<lpage>32</lpage>. .<?supplied-pmid 16968225?><pub-id pub-id-type="pmid">16968225</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Biller</surname><given-names>L</given-names></name>, <name><surname>Schmidt</surname><given-names>H</given-names></name>, <name><surname>Krause</surname><given-names>E</given-names></name>, <name><surname>Gelhaus</surname><given-names>C</given-names></name>, <name><surname>Matthiesen</surname><given-names>J</given-names></name>, <name><surname>Handal</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Comparison of two genetically related Entamoeba histolytica cell lines derived from the same isolate with different pathogenic properties</article-title>. <source>Proteomics</source>. <year>2009</year>; <volume>9</volume>(<issue>17</issue>):<fpage>4107</fpage>&#x02013;<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/pmic.200900022">10.1002/pmic.200900022</ext-link></comment><?supplied-pmid 19688750?><pub-id pub-id-type="pmid">19688750</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Biller</surname><given-names>L</given-names></name>, <name><surname>Davis</surname><given-names>PH</given-names></name>, <name><surname>Tillack</surname><given-names>M</given-names></name>, <name><surname>Matthiesen</surname><given-names>J</given-names></name>, <name><surname>Lotter</surname><given-names>H</given-names></name>, <name><surname>Stanley</surname><given-names>SL</given-names><suffix>Jr.</suffix></name>, <etal>et al</etal>
<article-title>Differences in the transcriptome signatures of two genetically related Entamoeba histolytica cell lines derived from the same isolate with different pathogenic properties</article-title>. <source>BMC Genomics</source>. <year>2010</year>; <volume>11</volume>:<fpage>63</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2164-11-63">10.1186/1471-2164-11-63</ext-link></comment><?supplied-pmid 20102605?><pub-id pub-id-type="pmid">20102605</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Biller</surname><given-names>L</given-names></name>, <name><surname>Matthiesen</surname><given-names>J</given-names></name>, <name><surname>Kuhne</surname><given-names>V</given-names></name>, <name><surname>Lotter</surname><given-names>H</given-names></name>, <name><surname>Handal</surname><given-names>G</given-names></name>, <name><surname>Nozaki</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>The Cell Surface Proteome of Entamoeba histolytica</article-title>. <source>Mol Cell Proteomics</source>. <year>2014</year>; <volume>13</volume>(<issue>1</issue>):<fpage>132</fpage>&#x02013;<lpage>44</lpage>. Epub 2013/10/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/mcp.M113.031393">10.1074/mcp.M113.031393</ext-link></comment> .<?supplied-pmid 24136294?><pub-id pub-id-type="pmid">24136294</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Penuliar</surname><given-names>GM</given-names></name>, <name><surname>Furukawa</surname><given-names>A</given-names></name>, <name><surname>Sato</surname><given-names>D</given-names></name>, <name><surname>Nozaki</surname><given-names>T</given-names></name>. <article-title>Mechanism of trifluoromethionine resistance in Entamoeba histolytica</article-title>. <source>J Antimicrob Chemother</source>. <year>2011</year>;<volume>66</volume>(<issue>9</issue>):<fpage>2045</fpage>&#x02013;<lpage>52</lpage>. Epub 2011/06/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jac/dkr238">10.1093/jac/dkr238</ext-link></comment> .<?supplied-pmid 21676903?><pub-id pub-id-type="pmid">21676903</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Penuliar</surname><given-names>GM</given-names></name>, <name><surname>Furukawa</surname><given-names>A</given-names></name>, <name><surname>Nakada-Tsukui</surname><given-names>K</given-names></name>, <name><surname>Husain</surname><given-names>A</given-names></name>, <name><surname>Sato</surname><given-names>D</given-names></name>, <name><surname>Nozaki</surname><given-names>T</given-names></name>. <article-title>Transcriptional and functional analysis of trifluoromethionine resistance in Entamoeba histolytica</article-title>. <source>J Antimicrob Chemother</source>. <year>2012</year>; <volume>67</volume>(<issue>2</issue>):<fpage>375</fpage>&#x02013;<lpage>86</lpage>. Epub 2011/11/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jac/dkr484">10.1093/jac/dkr484</ext-link></comment> .<?supplied-pmid 22110087?><pub-id pub-id-type="pmid">22110087</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>McCoy</surname><given-names>JJ</given-names></name>, <name><surname>Mann</surname><given-names>BJ</given-names></name>, <name><surname>Vedvick</surname><given-names>TS</given-names></name>, <name><surname>Pak</surname><given-names>Y</given-names></name>, <name><surname>Heimark</surname><given-names>DB</given-names></name>, <name><surname>Petri</surname><given-names>WA</given-names><suffix>Jr</suffix></name>. <article-title>Structural analysis of the light subunit of the Entamoeba histolytica galactose-specific adherence lectin</article-title>. <source>J Biol Chem</source>. <year>1993</year>; <volume>268</volume>(<issue>32</issue>):<fpage>24223</fpage>&#x02013;<lpage>31</lpage>. Epub 1993/11/15. .<?supplied-pmid 8226970?><pub-id pub-id-type="pmid">8226970</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>McCoy</surname><given-names>JJ</given-names></name>, <name><surname>Weaver</surname><given-names>AM</given-names></name>, <name><surname>Petri</surname><given-names>WA</given-names><suffix>Jr</suffix></name>. <article-title>Use of monoclonal anti-light subunit antibodies to study the structure and function of the Entamoeba histolytica Gal/GalNAc adherence lectin</article-title>. <source>Glycoconj J</source>. <year>1994</year>; <volume>11</volume>(<issue>5</issue>):<fpage>432</fpage>&#x02013;<lpage>6</lpage>. Epub 1994/10/01. .<?supplied-pmid 7696848?><pub-id pub-id-type="pmid">7696848</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Serrano-Luna</surname><given-names>J</given-names></name>, <name><surname>Gutierrez-Meza</surname><given-names>M</given-names></name>, <name><surname>Mejia-Zepeda</surname><given-names>R</given-names></name>, <name><surname>Galindo-Gomez</surname><given-names>S</given-names></name>, <name><surname>Tsutsumi</surname><given-names>V</given-names></name>, <name><surname>Shibayama</surname><given-names>M</given-names></name>. <article-title>Effect of phosphatidylcholine-cholesterol liposomes on Entamoeba histolytica virulence</article-title>. <source>Can J Microbiol</source>. <year>2010</year>; <volume>56</volume>(<issue>12</issue>):<fpage>987</fpage>&#x02013;<lpage>95</lpage>. Epub 2010/12/18. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1139/W10-088">10.1139/W10-088</ext-link></comment> .<?supplied-pmid 21164568?><pub-id pub-id-type="pmid">21164568</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>S</given-names></name>, <name><surname>Ghosh</surname><given-names>P</given-names></name>, <name><surname>Naik</surname><given-names>S</given-names></name>, <name><surname>Naik</surname><given-names>SR</given-names></name>. <article-title>Proteinase activity &#x00026; virulence of Entamoeba histolytica on passage through hamster liver</article-title>. <source>Indian J Med Res</source>. <year>1998</year>; <volume>107</volume>:<fpage>173</fpage>&#x02013;<lpage>7</lpage>. Epub 1998/05/30. .<?supplied-pmid 9604544?><pub-id pub-id-type="pmid">9604544</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Bos</surname><given-names>HJ</given-names></name>, <name><surname>van de Griend</surname><given-names>RJ</given-names></name>. <article-title>Virulence and toxicity of axenic Entamoeba histolytica</article-title>. <source>Nature</source>. <year>1977</year>; <volume>265</volume>(<issue>5592</issue>):<fpage>341</fpage>&#x02013;<lpage>3</lpage>. Epub 1977/01/27. .<?supplied-pmid 189211?><pub-id pub-id-type="pmid">189211</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Monfort</surname><given-names>SL</given-names></name>, <name><surname>Asher</surname><given-names>GW</given-names></name>, <name><surname>Wildt</surname><given-names>DE</given-names></name>, <name><surname>Wood</surname><given-names>TC</given-names></name>, <name><surname>Schiewe</surname><given-names>MC</given-names></name>, <name><surname>Williamson</surname><given-names>LR</given-names></name>, <etal>et al</etal>
<article-title>Phagocytosis and proteinase activity are not related to pathogenicity of E. histolytica</article-title>. <source>Parasitol Res</source>. <year>1993</year>; <volume>79</volume>:<fpage>160</fpage>&#x02013;<lpage>2</lpage>. <?supplied-pmid 8475035?><pub-id pub-id-type="pmid">8475035</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Gonzalez-Garza</surname><given-names>MT</given-names></name>, <name><surname>Castro-Garza</surname><given-names>J</given-names></name>, <name><surname>Cruz-Vega</surname><given-names>DE</given-names></name>, <name><surname>Vargas-Villarreal</surname><given-names>J</given-names></name>, <name><surname>Carranza-Rosales</surname><given-names>P</given-names></name>, <name><surname>Mata-Cardenas</surname><given-names>BD</given-names></name>, <etal>et al</etal>
<article-title>Entamoeba histolytica: diminution of erythrophagocytosis, phospholipase A(2), and hemolytic activities is related to virulence impairment in long-term axenic cultures</article-title>. <source>Exp Parasitol</source>. <year>2000</year>; <volume>96</volume>(<issue>2</issue>):<fpage>116</fpage>&#x02013;<lpage>9</lpage>. Epub 2000/10/29. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/expr.2000.4554">10.1006/expr.2000.4554</ext-link></comment> .<?supplied-pmid 11052870?><pub-id pub-id-type="pmid">11052870</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Lotter</surname><given-names>H</given-names></name>, <name><surname>Jacobs</surname><given-names>T</given-names></name>, <name><surname>Gaworski</surname><given-names>I</given-names></name>, <name><surname>Tannich</surname><given-names>E</given-names></name>. <article-title>Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease</article-title>. <source>Infect Immun</source>. <year>2006</year>; <volume>74</volume>(<issue>1</issue>):<fpage>118</fpage>&#x02013;<lpage>24</lpage>. .<?supplied-pmid 16368964?><pub-id pub-id-type="pmid">16368964</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Helk</surname><given-names>E</given-names></name>, <name><surname>Bernin</surname><given-names>H</given-names></name>, <name><surname>Ernst</surname><given-names>T</given-names></name>, <name><surname>Ittrich</surname><given-names>H</given-names></name>, <name><surname>Jacobs</surname><given-names>T</given-names></name>, <name><surname>Heeren</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>TNFalpha-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infection</article-title>. <source>PLoS pathog</source>. <year>2013</year>; <volume>9</volume>(<issue>1</issue>):<fpage>e1003096</fpage> Epub 2013/01/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1003096">10.1371/journal.ppat.1003096</ext-link></comment> ; PubMed Central PMCID: PMC3536671.<?supplied-pmid 23300453?><pub-id pub-id-type="pmid">23300453</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Noll</surname><given-names>J</given-names></name>, <name><surname>Helk</surname><given-names>E</given-names></name>, <name><surname>Fehling</surname><given-names>H</given-names></name>, <name><surname>Bernin</surname><given-names>H</given-names></name>, <name><surname>Marggraff</surname><given-names>C</given-names></name>, <name><surname>Jacobs</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>IL-23 prevents IL-13-dependent tissue repair associated with Ly6C(lo) monocytes in Entamoeba histolytica-induced liver damage</article-title>. <source>J Hepatol</source>. <year>2016</year>; <volume>64</volume>(<issue>5</issue>):<fpage>1147</fpage>&#x02013;<lpage>57</lpage>. Epub 2016/01/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jhep.2016.01.013">10.1016/j.jhep.2016.01.013</ext-link></comment> .<?supplied-pmid 26809113?><pub-id pub-id-type="pmid">26809113</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Marie</surname><given-names>C</given-names></name>, <name><surname>Petri</surname><given-names>WA</given-names><suffix>Jr</suffix></name>. <article-title>Regulation of virulence of Entamoeba histolytica</article-title>. <source>Annu Rev Microbiol</source>. <year>2014</year>; <volume>68</volume>:<fpage>493</fpage>&#x02013;<lpage>520</lpage>. Epub 2014/07/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-micro-091313-103550">10.1146/annurev-micro-091313-103550</ext-link></comment> .<?supplied-pmid 25002094?><pub-id pub-id-type="pmid">25002094</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Nakada-Tsukui</surname><given-names>K</given-names></name>, <name><surname>Nozaki</surname><given-names>T</given-names></name>. <article-title>Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica</article-title>. <source>Front Immunol</source>. <year>2016</year>; <volume>7</volume>:<fpage>175</fpage> Epub 2016/06/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fimmu.2016.00175">10.3389/fimmu.2016.00175</ext-link></comment> ; PubMed Central PMCID: PMC4863898.<?supplied-pmid 27242782?><pub-id pub-id-type="pmid">27242782</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Gadasi</surname><given-names>H</given-names></name>, <name><surname>Kessler</surname><given-names>E</given-names></name>. <article-title>Correlation of virulence and collagenolytic activity in Entamoeba histolytica</article-title>. <source>Infect Immun</source>. <year>1983</year>; <volume>39</volume>(<issue>2</issue>):<fpage>528</fpage>&#x02013;<lpage>31</lpage>. <?supplied-pmid 6299942?><pub-id pub-id-type="pmid">6299942</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Keene</surname><given-names>WE</given-names></name>, <name><surname>Hidalgo</surname><given-names>ME</given-names></name>, <name><surname>Orozco</surname><given-names>E</given-names></name>, <name><surname>McKerrow</surname><given-names>JH</given-names></name>. <article-title>Entamoeba histolytica: correlation of the cytopathic effect of virulent trophozoites with secretion of a cysteine proteinase</article-title>. <source>Exp Parasitol</source>. <year>1990</year>; <volume>71</volume>(<issue>2</issue>):<fpage>199</fpage>&#x02013;<lpage>206</lpage>. <?supplied-pmid 2373188?><pub-id pub-id-type="pmid">2373188</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Lushbaugh</surname><given-names>WB</given-names></name>, <name><surname>Hofbauer</surname><given-names>AF</given-names></name>, <name><surname>Kairalla</surname><given-names>AA</given-names></name>, <name><surname>Cantey</surname><given-names>JR</given-names></name>, <name><surname>Pittman</surname><given-names>FE</given-names></name>. <article-title>Relationship of cytotoxins of axenically cultivated Entamoeba histolytica to virulence</article-title>. <source>Gastroenterology</source>. <year>1984</year>;<volume>86</volume>(<issue>6</issue>):<fpage>1488</fpage>&#x02013;<lpage>95</lpage>. Epub 1984/06/01. .<?supplied-pmid 6325286?><pub-id pub-id-type="pmid">6325286</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Lushbaugh</surname><given-names>WB</given-names></name>, <name><surname>Hofbauer</surname><given-names>AF</given-names></name>, <name><surname>Pittman</surname><given-names>FE</given-names></name>. <article-title>Entamoeba histolytica: purification of cathepsin B</article-title>. <source>Exp Parasitol</source>. <year>1985</year>; <volume>59</volume>(<issue>3</issue>):<fpage>328</fpage>&#x02013;<lpage>36</lpage>. <?supplied-pmid 2860002?><pub-id pub-id-type="pmid">2860002</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>E</given-names></name>, <name><surname>Yang</surname><given-names>WG</given-names></name>, <name><surname>Zhang</surname><given-names>T</given-names></name>, <name><surname>Stanley</surname><given-names>SL</given-names><suffix>Jr</suffix></name>. <article-title>Interaction of laminin with Entamoeba histolytica cysteine proteinases and its effect on amebic pathogenesis</article-title>. <source>Infect Immun</source>. <year>1995</year>; <volume>63</volume>(<issue>10</issue>):<fpage>4150</fpage>&#x02013;<lpage>3</lpage>. <?supplied-pmid 7558332?><pub-id pub-id-type="pmid">7558332</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Stanley</surname><given-names>SL</given-names><suffix>Jr.</suffix></name>, <name><surname>Zhang</surname><given-names>T</given-names></name>, <name><surname>Rubin</surname><given-names>D</given-names></name>, <name><surname>Li</surname><given-names>E</given-names></name>. <article-title>Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice</article-title>. <source>Infect Immun</source>. <year>1995</year>; <volume>63</volume>(<issue>4</issue>):<fpage>1587</fpage>&#x02013;<lpage>90</lpage>. <?supplied-pmid 7890426?><pub-id pub-id-type="pmid">7890426</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Seydel</surname><given-names>KB</given-names></name>, <name><surname>Li</surname><given-names>E</given-names></name>, <name><surname>Ankri</surname><given-names>S</given-names></name>, <name><surname>Mirelman</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis</article-title>. <source>Mol Microbiol</source>. <year>2000</year>; <volume>37</volume>(<issue>3</issue>):<fpage>542</fpage>&#x02013;<lpage>8</lpage>. .<?supplied-pmid 10931347?><pub-id pub-id-type="pmid">10931347</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Tillack</surname><given-names>M</given-names></name>, <name><surname>Nowak</surname><given-names>N</given-names></name>, <name><surname>Lotter</surname><given-names>H</given-names></name>, <name><surname>Bracha</surname><given-names>R</given-names></name>, <name><surname>Mirelman</surname><given-names>D</given-names></name>, <name><surname>Tannich</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Increased expression of the major cysteine proteinases by stable episomal transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba histolytica</article-title>. <source>Mol Biochem Parasitol</source>. <year>2006</year>;<volume>149</volume>(<issue>1</issue>):<fpage>58</fpage>&#x02013;<lpage>64</lpage>. .<?supplied-pmid 16753229?><pub-id pub-id-type="pmid">16753229</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Bansal</surname><given-names>D</given-names></name>, <name><surname>Ave</surname><given-names>P</given-names></name>, <name><surname>Kerneis</surname><given-names>S</given-names></name>, <name><surname>Frileux</surname><given-names>P</given-names></name>, <name><surname>Boche</surname><given-names>O</given-names></name>, <name><surname>Baglin</surname><given-names>AC</given-names></name>, <etal>et al</etal>
<article-title>An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2009</year>; <volume>3</volume>(<issue>11</issue>):<fpage>e551</fpage> Epub 2009/11/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000551">10.1371/journal.pntd.0000551</ext-link></comment> ; PubMed Central PMCID: PMC2777411.<?supplied-pmid 19936071?><pub-id pub-id-type="pmid">19936071</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Thibeaux</surname><given-names>R</given-names></name>, <name><surname>Dufour</surname><given-names>A</given-names></name>, <name><surname>Roux</surname><given-names>P</given-names></name>, <name><surname>Bernier</surname><given-names>M</given-names></name>, <name><surname>Baglin</surname><given-names>AC</given-names></name>, <name><surname>Frileux</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Newly visualized fibrillar collagen scaffolds dictate Entamoeba histolytica invasion route in the human colon</article-title>. <source>Cell Microbiol</source>. <year>2012</year>; <volume>14</volume>(<issue>5</issue>):<fpage>609</fpage>&#x02013;<lpage>21</lpage>. Epub 2012/01/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1462-5822.2012.01752.x">10.1111/j.1462-5822.2012.01752.x</ext-link></comment> .<?supplied-pmid 22233454?><pub-id pub-id-type="pmid">22233454</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Thibeaux</surname><given-names>R</given-names></name>, <name><surname>Ave</surname><given-names>P</given-names></name>, <name><surname>Bernier</surname><given-names>M</given-names></name>, <name><surname>Morcelet</surname><given-names>M</given-names></name>, <name><surname>Frileux</surname><given-names>P</given-names></name>, <name><surname>Guillen</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>The parasite Entamoeba histolytica exploits the activities of human matrix metalloproteinases to invade colonic tissue</article-title>. <source>Nat Commun</source>. <year>2014</year>; <volume>5</volume>:<fpage>5142</fpage> Epub 2014/10/08. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms6142">10.1038/ncomms6142</ext-link></comment> .<?supplied-pmid 25291063?><pub-id pub-id-type="pmid">25291063</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Cornick</surname><given-names>S</given-names></name>, <name><surname>Moreau</surname><given-names>F</given-names></name>, <name><surname>Chadee</surname><given-names>K</given-names></name>. <article-title>Entamoeba histolytica Cysteine Proteinase 5 Evokes mucin exocytosis from colonic goblet cells via alphavbeta3 integrin</article-title>. <source>PLoS Pathog</source>. <year>2016</year>; <volume>12</volume>(<issue>4</issue>):<fpage>e1005579</fpage> Epub 2016/04/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1005579">10.1371/journal.ppat.1005579</ext-link></comment> ; PubMed Central PMCID: PMC4830554.<?supplied-pmid 27073869?><pub-id pub-id-type="pmid">27073869</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Trissl</surname><given-names>D</given-names></name>, <name><surname>Martinez-Palomo</surname><given-names>A</given-names></name>, <name><surname>de la Torre</surname><given-names>M</given-names></name>, <name><surname>de la Hoz</surname><given-names>R</given-names></name>, <name><surname>Perez de Suarez</surname><given-names>E</given-names></name>. <article-title>Surface properties of Entamoeba: increased rates of human erythrocyte phagocytosis in pathogenic strains</article-title>. <source>J Exp Med</source>. <year>1978</year>; <volume>148</volume>(<issue>5</issue>):<fpage>1137</fpage>&#x02013;<lpage>43</lpage>. Epub 1978/11/01. ; PubMed Central PMCID: PMC2185040.<?supplied-pmid 722237?><pub-id pub-id-type="pmid">722237</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Mukherjee</surname><given-names>RM</given-names></name>, <name><surname>Bhol</surname><given-names>KC</given-names></name>, <name><surname>Mehra</surname><given-names>S</given-names></name>, <name><surname>Maitra</surname><given-names>TK</given-names></name>, <name><surname>Jalan</surname><given-names>KN</given-names></name>. <article-title>Study of Entamoeba histolytica isolates from Calcutta with special reference to their zymodeme, animal pathogenicity and erythrophagocytosis</article-title>. <source>J Diarrhoeal Dis Res</source>. <year>1991</year>; <volume>9</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>5</lpage>. Epub 1991/03/01. .<?supplied-pmid 1869796?><pub-id pub-id-type="pmid">1869796</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Orozco</surname><given-names>E</given-names></name>, <name><surname>Guarneros</surname><given-names>G</given-names></name>, <name><surname>Martinez-Palomo</surname><given-names>A</given-names></name>, <name><surname>Sanchez</surname><given-names>T</given-names></name>. <article-title>Entamoeba histolytica. Phagocytosis as a virulence factor</article-title>. <source>J Exp Med</source>. <year>1983</year>; <volume>158</volume>(<issue>5</issue>):<fpage>1511</fpage>&#x02013;<lpage>21</lpage>. .<?supplied-pmid 6313842?><pub-id pub-id-type="pmid">6313842</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Orozco</surname><given-names>E</given-names></name>, <name><surname>Suarez</surname><given-names>ME</given-names></name>, <name><surname>Sanchez</surname><given-names>T</given-names></name>. <article-title>Differences in adhesion, phagocytosis and virulence of clones from Entamoeba histolytica, strain HM1:IMSS</article-title>. <source>Int J Parasitol</source>. <year>1985</year>; <volume>15</volume>(<issue>6</issue>):<fpage>655</fpage>&#x02013;<lpage>60</lpage>. Epub 1985/12/01. .<?supplied-pmid 2869003?><pub-id pub-id-type="pmid">2869003</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Tsutsumi</surname><given-names>V</given-names></name>, <name><surname>Ramirez-Rosales</surname><given-names>A</given-names></name>, <name><surname>Lanz-Mendoza</surname><given-names>H</given-names></name>, <name><surname>Shibayama</surname><given-names>M</given-names></name>, <name><surname>Chavez</surname><given-names>B</given-names></name>, <name><surname>Rangel-Lopez</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Entamoeba histolytica: erythrophagocytosis, collagenolysis, and liver abscess production as virulence markers</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>1992</year>; <volume>86</volume>(<issue>2</issue>):<fpage>170</fpage>&#x02013;<lpage>2</lpage>. Epub 1992/03/01. .<?supplied-pmid 1440779?><pub-id pub-id-type="pmid">1440779</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Ralston</surname><given-names>KS</given-names></name>. <article-title>Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and beyond</article-title>. <source>Curr Opin Microbiol</source>. <year>2015</year>; <volume>28</volume>:<fpage>26</fpage>&#x02013;<lpage>35</lpage>. Epub 2015/08/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.mib.2015.07.009">10.1016/j.mib.2015.07.009</ext-link></comment> ; PubMed Central PMCID: PMC4542054.<?supplied-pmid 26277085?><pub-id pub-id-type="pmid">26277085</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Ralston</surname><given-names>KS</given-names></name>, <name><surname>Solga</surname><given-names>MD</given-names></name>, <name><surname>Mackey-Lawrence</surname><given-names>NM</given-names></name>, <name><surname>Somlata</surname></name>, <name><surname>Bhattacharya</surname><given-names>A</given-names></name>, <name><surname>Petri</surname><given-names>WA</given-names><suffix>Jr</suffix></name>. <article-title>Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion</article-title>. <source>Nature</source>. <year>2014</year>; <volume>508</volume>(<issue>7497</issue>):<fpage>526</fpage>&#x02013;<lpage>30</lpage>. Epub 2014/04/11. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature13242">10.1038/nature13242</ext-link></comment> ; PubMed Central PMCID: PMC4006097.<?supplied-pmid 24717428?><pub-id pub-id-type="pmid">24717428</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Balderas-Renteria</surname><given-names>I</given-names></name>, <name><surname>Garcia-Lazaro</surname><given-names>JF</given-names></name>, <name><surname>Carranza-Rosales</surname><given-names>P</given-names></name>, <name><surname>Morales-Ramos</surname><given-names>LH</given-names></name>, <name><surname>Galan-Wong</surname><given-names>LJ</given-names></name>, <name><surname>Munoz-Espinosa</surname><given-names>LE</given-names></name>. <article-title>Transcriptional upregulation of genes related to virulence activation in Entamoeba histolytica</article-title>. <source>Archives of medical research</source>. <year>2007</year>; <volume>38</volume>(<issue>4</issue>):<fpage>372</fpage>&#x02013;<lpage>9</lpage>. Epub 2007/04/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.arcmed.2007.01.003">10.1016/j.arcmed.2007.01.003</ext-link></comment> .<?supplied-pmid 17416282?><pub-id pub-id-type="pmid">17416282</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Keller</surname><given-names>F</given-names></name>, <name><surname>Walter</surname><given-names>C</given-names></name>, <name><surname>Lohden</surname><given-names>U</given-names></name>, <name><surname>Hanke</surname><given-names>W</given-names></name>, <name><surname>Bakker-Grunwald</surname><given-names>T</given-names></name>, <name><surname>Trissl</surname><given-names>D</given-names></name>. <article-title>Pathogenic and non-pathogenic Entamoeba: pore formation and hemolytic activity</article-title>. <source>J Protozool</source>. <year>1988</year>; <volume>35</volume>(<issue>3</issue>):<fpage>359</fpage>&#x02013;<lpage>65</lpage>. Epub 1988/08/01. .<?supplied-pmid 2460621?><pub-id pub-id-type="pmid">2460621</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Que</surname><given-names>X</given-names></name>, <name><surname>Reed</surname><given-names>SL</given-names></name>. <article-title>Cysteine proteinases and the pathogenesis of amebiasis</article-title>. <source>Clin Microbiol Rev</source>. <year>2000</year>; <volume>13</volume>(<issue>2</issue>):<fpage>196</fpage>&#x02013;<lpage>206</lpage>. .<?supplied-pmid 10755997?><pub-id pub-id-type="pmid">10755997</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Petri</surname><given-names>WA</given-names><suffix>Jr.</suffix></name>, <name><surname>Ravdin</surname><given-names>JI</given-names></name>. <article-title>Cytopathogenicity of Entamoeba histolytica: the role of amebic adherence and contact-dependent cytolysis in pathogenesis</article-title>. <source>Eur J Epidemiol</source>. <year>1987</year>; <volume>3</volume>(<issue>2</issue>):<fpage>123</fpage>&#x02013;<lpage>36</lpage>. .<?supplied-pmid 2886360?><pub-id pub-id-type="pmid">2886360</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Moreno</surname><given-names>H</given-names></name>, <name><surname>Linford</surname><given-names>AS</given-names></name>, <name><surname>Gilchrist</surname><given-names>CA</given-names></name>, <name><surname>Petri</surname><given-names>WA</given-names><suffix>Jr</suffix></name>. <article-title>Phospholipid-binding protein EhC2A mediates calcium-dependent translocation of transcription factor URE3-BP to the plasma membrane of Entamoeba histolytica</article-title>. <source>Eukaryotic Cell</source>. <year>2010</year>; <volume>9</volume>(<issue>5</issue>):<fpage>695</fpage>&#x02013;<lpage>704</lpage>. Epub 2009/12/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/EC.00346-09">10.1128/EC.00346-09</ext-link></comment> ; PubMed Central PMCID: PMC2863961.<?supplied-pmid 20023071?><pub-id pub-id-type="pmid">20023071</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Olivier</surname><given-names>M</given-names></name>, <name><surname>Atayde</surname><given-names>VD</given-names></name>, <name><surname>Isnard</surname><given-names>A</given-names></name>, <name><surname>Hassani</surname><given-names>K</given-names></name>, <name><surname>Shio</surname><given-names>MT</given-names></name>. <article-title>Leishmania virulence factors: focus on the metalloprotease GP63</article-title>. <source>Microbes Infect</source>. <year>2012</year>; <volume>14</volume>(<issue>15</issue>):<fpage>1377</fpage>&#x02013;<lpage>89</lpage>. Epub 2012/06/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.micinf.2012.05.014">10.1016/j.micinf.2012.05.014</ext-link></comment> .<?supplied-pmid 22683718?><pub-id pub-id-type="pmid">22683718</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Isnard</surname><given-names>A</given-names></name>, <name><surname>Shio</surname><given-names>MT</given-names></name>, <name><surname>Olivier</surname><given-names>M</given-names></name>. <article-title>Impact of Leishmania metalloprotease GP63 on macrophage signaling</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2012</year>; <volume>2</volume>:<fpage>72</fpage> Epub 2012/08/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fcimb.2012.00072">10.3389/fcimb.2012.00072</ext-link></comment> ; PubMed Central PMCID: PMC3417651.<?supplied-pmid 22919663?><pub-id pub-id-type="pmid">22919663</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Teixeira</surname><given-names>JE</given-names></name>, <name><surname>Sateriale</surname><given-names>A</given-names></name>, <name><surname>Bessoff</surname><given-names>KE</given-names></name>, <name><surname>Huston</surname><given-names>CD</given-names></name>. <article-title>Control of Entamoeba histolytica adherence involves metallosurface protease 1, an M8 family surface metalloprotease with homology to leishmanolysin</article-title>. <source>Infect Immun</source>. <year>2012</year>; <volume>80</volume>(<issue>6</issue>):<fpage>2165</fpage>&#x02013;<lpage>76</lpage>. Epub 2012/03/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.06389-11">10.1128/IAI.06389-11</ext-link></comment> ; PubMed Central PMCID: PMC3370588.<?supplied-pmid 22451519?><pub-id pub-id-type="pmid">22451519</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>S</given-names></name>, <name><surname>Yuan</surname><given-names>S</given-names></name>, <name><surname>Dong</surname><given-names>M</given-names></name>, <name><surname>Su</surname><given-names>J</given-names></name>, <name><surname>Yu</surname><given-names>C</given-names></name>, <name><surname>Shen</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>The phylogenetic analysis of tetraspanins projects the evolution of cell-cell interactions from unicellular to multicellular organisms</article-title>. <source>Genomics</source>. <year>2005</year>; <volume>86</volume>(<issue>6</issue>):<fpage>674</fpage>&#x02013;<lpage>84</lpage>. Epub 2005/10/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ygeno.2005.08.004">10.1016/j.ygeno.2005.08.004</ext-link></comment> .<?supplied-pmid 16242907?><pub-id pub-id-type="pmid">16242907</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Hemler</surname><given-names>ME</given-names></name>. <article-title>Tetraspanin functions and associated microdomains</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2005</year>; <volume>6</volume>(<issue>10</issue>):<fpage>801</fpage>&#x02013;<lpage>11</lpage>. Epub 2005/11/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrm1736">10.1038/nrm1736</ext-link></comment> .<?supplied-pmid 16314869?><pub-id pub-id-type="pmid">16314869</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Coceres</surname><given-names>VM</given-names></name>, <name><surname>Alonso</surname><given-names>AM</given-names></name>, <name><surname>Nievas</surname><given-names>YR</given-names></name>, <name><surname>Midlej</surname><given-names>V</given-names></name>, <name><surname>Frontera</surname><given-names>L</given-names></name>, <name><surname>Benchimol</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>The C-terminal tail of tetraspanin proteins regulates their intracellular distribution in the parasite Trichomonas vaginalis</article-title>. <source>Cell Microbiol</source>. <year>2015</year>; <volume>17</volume>(<issue>8</issue>):<fpage>1217</fpage>&#x02013;<lpage>29</lpage>. Epub 2015/02/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/cmi.12431">10.1111/cmi.12431</ext-link></comment> .<?supplied-pmid 25703821?><pub-id pub-id-type="pmid">25703821</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>PH</given-names></name>, <name><surname>Chen</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Clark</surname><given-names>CG</given-names></name>, <name><surname>Townsend</surname><given-names>RR</given-names></name>, <name><surname>Stanley</surname><given-names>SL</given-names><suffix>Jr</suffix></name>. <article-title>Proteomic comparison of Entamoeba histolytica and Entamoeba dispar and the role of E. histolytica alcohol dehydrogenase 3 in virulence</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2009</year>; <volume>3</volume>(<issue>4</issue>):<fpage>e415</fpage> Epub 2009/04/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000415">10.1371/journal.pntd.0000415</ext-link></comment> ; PubMed Central PMCID: PMC2663792.<?supplied-pmid 19365541?><pub-id pub-id-type="pmid">19365541</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Zerial</surname><given-names>M</given-names></name>, <name><surname>McBride</surname><given-names>H</given-names></name>. <article-title>Rab proteins as membrane organizers</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2001</year>; <volume>2</volume>(<issue>2</issue>):<fpage>107</fpage>&#x02013;<lpage>17</lpage>. .<?supplied-pmid 11252952?><pub-id pub-id-type="pmid">11252952</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Saito-Nakano</surname><given-names>Y</given-names></name>, <name><surname>Loftus</surname><given-names>BJ</given-names></name>, <name><surname>Hall</surname><given-names>N</given-names></name>, <name><surname>Nozaki</surname><given-names>T</given-names></name>. <article-title>The diversity of Rab GTPases in Entamoeba histolytica</article-title>. <source>Exp Parasitol</source>. <year>2005</year>; <volume>110</volume>(<issue>3</issue>):<fpage>244</fpage>&#x02013;<lpage>52</lpage>. .<?supplied-pmid 15955319?><pub-id pub-id-type="pmid">15955319</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Saito-Nakano</surname><given-names>Y</given-names></name>, <name><surname>Mitra</surname><given-names>BN</given-names></name>, <name><surname>Nakada-Tsukui</surname><given-names>K</given-names></name>, <name><surname>Sato</surname><given-names>D</given-names></name>, <name><surname>Nozaki</surname><given-names>T</given-names></name>. <article-title>Two Rab7 isotypes, EhRab7A and EhRab7B, play distinct roles in biogenesis of lysosomes and phagosomes in the enteric protozoan parasite Entamoeba histolytica</article-title>. <source>Cell Microbiol</source>. <year>2007</year>; <volume>9</volume>(<issue>7</issue>):<fpage>1796</fpage>&#x02013;<lpage>808</lpage>. .<?supplied-pmid 17359234?><pub-id pub-id-type="pmid">17359234</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Saito-Nakano</surname><given-names>Y</given-names></name>, <name><surname>Yasuda</surname><given-names>T</given-names></name>, <name><surname>Nakada-Tsukui</surname><given-names>K</given-names></name>, <name><surname>Leippe</surname><given-names>M</given-names></name>, <name><surname>Nozaki</surname><given-names>T</given-names></name>. <article-title>Rab5-associated vacuoles play a unique role in phagocytosis of the enteric protozoan parasite Entamoeba histolytica</article-title>. <source>J Biol Chem</source>. <year>2004</year>; <volume>279</volume>(<issue>47</issue>):<fpage>49497</fpage>&#x02013;<lpage>507</lpage>. Epub 2004/09/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M403987200">10.1074/jbc.M403987200</ext-link></comment> .<?supplied-pmid 15347665?><pub-id pub-id-type="pmid">15347665</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Nakada-Tsukui</surname><given-names>K</given-names></name>, <name><surname>Saito-Nakano</surname><given-names>Y</given-names></name>, <name><surname>Ali</surname><given-names>V</given-names></name>, <name><surname>Nozaki</surname><given-names>T</given-names></name>. <article-title>A retromerlike complex is a novel Rab7 effector that is involved in the transport of the virulence factor cysteine protease in the enteric protozoan parasite Entamoeba histolytica</article-title>. <source>Mol Biol Cell</source>. <year>2005</year>; <volume>16</volume>(<issue>11</issue>):<fpage>5294</fpage>&#x02013;<lpage>303</lpage>. .<?supplied-pmid 16120649?><pub-id pub-id-type="pmid">16120649</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Nozaki</surname><given-names>T</given-names></name>, <name><surname>Nakada-Tsukui</surname><given-names>K</given-names></name>. <article-title>Membrane trafficking as a virulence mechanism of the enteric protozoan parasite Entamoeba histolytica</article-title>. <source>Parasitol Res</source>. <year>2006</year>; <volume>98</volume>(<issue>3</issue>):<fpage>179</fpage>&#x02013;<lpage>83</lpage>. Epub 2005/12/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00436-005-0079-6">10.1007/s00436-005-0079-6</ext-link></comment> .<?supplied-pmid 16374616?><pub-id pub-id-type="pmid">16374616</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Diamond</surname><given-names>LS</given-names></name>, <name><surname>Harlow</surname><given-names>DR</given-names></name>, <name><surname>Cunnick</surname><given-names>CC</given-names></name>. <article-title>A new medium for axenic cultivation of <italic>Entamoeba histolytica</italic> and other <italic>Entamoeba</italic></article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>1978</year>; <volume>72</volume>:<fpage>431</fpage>&#x02013;<lpage>2</lpage>. <?supplied-pmid 212851?><pub-id pub-id-type="pmid">212851</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Loftus</surname><given-names>B</given-names></name>, <name><surname>Anderson</surname><given-names>I</given-names></name>, <name><surname>Davies</surname><given-names>R</given-names></name>, <name><surname>Alsmark</surname><given-names>UC</given-names></name>, <name><surname>Samuelson</surname><given-names>J</given-names></name>, <name><surname>Amedeo</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>The genome of the protist parasite Entamoeba histolytica</article-title>. <source>Nature</source>. <year>2005</year>; <volume>433</volume>(<issue>7028</issue>):<fpage>865</fpage>&#x02013;<lpage>8</lpage>. .<?supplied-pmid 15729342?><pub-id pub-id-type="pmid">15729342</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Lotter</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>T</given-names></name>, <name><surname>Seydel</surname><given-names>KB</given-names></name>, <name><surname>Stanley</surname><given-names>SL</given-names><suffix>Jr.</suffix></name>, <name><surname>Tannich</surname><given-names>E</given-names></name>. <article-title>Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis</article-title>. <source>J Exp Med</source>. <year>1997</year>; <volume>185</volume>(<issue>10</issue>):<fpage>1793</fpage>&#x02013;<lpage>801</lpage>. <?supplied-pmid 9151705?><pub-id pub-id-type="pmid">9151705</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Ernst</surname><given-names>TM</given-names></name>, <name><surname>Fehling</surname><given-names>H</given-names></name>, <name><surname>Bernin</surname><given-names>H</given-names></name>, <name><surname>Zaruba</surname><given-names>MD</given-names></name>, <name><surname>Bruchhaus</surname><given-names>I</given-names></name>, <name><surname>Adam</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Magnetic Resonance Imaging of Pathogenic Protozoan Parasite Entamoeba histolytica Labeled With Superparamagnetic Iron Oxide Nanoparticles</article-title>. <source>Invest Radiol</source>. <year>2015</year>;<volume>50</volume>(<issue>10</issue>):<fpage>709</fpage>&#x02013;<lpage>18</lpage>. Epub 2015/07/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/RLI.0000000000000175">10.1097/RLI.0000000000000175</ext-link></comment> .<?supplied-pmid 26135016?><pub-id pub-id-type="pmid">26135016</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Livak</surname><given-names>KJ</given-names></name>, <name><surname>Schmittgen</surname><given-names>TD</given-names></name>. <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>. <source>Methods</source>. <year>2001</year>; <volume>25</volume>(<issue>4</issue>):<fpage>402</fpage>&#x02013;<lpage>8</lpage>. .<?supplied-pmid 11846609?><pub-id pub-id-type="pmid">11846609</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Langmead</surname><given-names>B</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name>. <article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nat Methods</source>. <year>2012</year>; <volume>9</volume>(<issue>4</issue>):<fpage>357</fpage>&#x02013;<lpage>9</lpage>. Epub 2012/03/06. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth.1923">10.1038/nmeth.1923</ext-link></comment> ; PubMed Central PMCID: PMC3322381.<?supplied-pmid 22388286?><pub-id pub-id-type="pmid">22388286</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Ashburner</surname><given-names>M</given-names></name>, <name><surname>Ball</surname><given-names>CA</given-names></name>, <name><surname>Blake</surname><given-names>JA</given-names></name>, <name><surname>Botstein</surname><given-names>D</given-names></name>, <name><surname>Butler</surname><given-names>H</given-names></name>, <name><surname>Cherry</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>Gene ontology: tool for the unification of biology. The Gene Ontology Consortium</article-title>. <source>Nat Genet</source>. <year>2000</year>; <volume>25</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02013;<lpage>9</lpage>. Epub 2000/05/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/75556">10.1038/75556</ext-link></comment> ; PubMed Central PMCID: PMC3037419.<?supplied-pmid 10802651?><pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Leippe</surname><given-names>M</given-names></name>, <name><surname>Sievertsen</surname><given-names>HJ</given-names></name>, <name><surname>Tannich</surname><given-names>E</given-names></name>, <name><surname>Horstmann</surname><given-names>RD</given-names></name>. <article-title>Spontaneous release of cysteine proteinases but not of pore-forming peptides by viable Entamoeba histolytica</article-title>. <source>Parasitology</source>. <year>1995</year>; <volume>111</volume>(<issue>Pt 5</issue>):<fpage>569</fpage>&#x02013;<lpage>74</lpage>. <?supplied-pmid 8559589?><pub-id pub-id-type="pmid">8559589</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Hellberg</surname><given-names>A</given-names></name>, <name><surname>Leippe</surname><given-names>M</given-names></name>, <name><surname>Bruchhaus</surname><given-names>I</given-names></name>. <article-title>Two major 'higher molecular mass proteinases' of Entamoeba histolytica are identified as cysteine proteinases 1 and 2</article-title>. <source>Mol Biochem Parasitol</source>. <year>2000</year>; <volume>105</volume>(<issue>2</issue>):<fpage>305</fpage>&#x02013;<lpage>9</lpage>. .<?supplied-pmid 10693753?><pub-id pub-id-type="pmid">10693753</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Bracha</surname><given-names>R</given-names></name>, <name><surname>Mirelman</surname><given-names>D</given-names></name>. <article-title>Virulence of Entamoeba histolytica trophozoites. Effects of bacteria, microaerobic conditions, and metronidazole</article-title>. <source>J Exp Med</source>. <year>1984</year>; <volume>160</volume>(<issue>2</issue>):<fpage>353</fpage>&#x02013;<lpage>68</lpage>. <?supplied-pmid 6088660?><pub-id pub-id-type="pmid">6088660</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Nickel</surname><given-names>R</given-names></name>, <name><surname>Tannich</surname><given-names>E</given-names></name>. <article-title>Transfection and transient expression of chloramphenicol acetyltransferase gene in the protozoan parasite Entamoeba histolytica</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1994</year>; <volume>91</volume>(<issue>15</issue>):<fpage>7095</fpage>&#x02013;<lpage>8</lpage>. .<?supplied-pmid 8041751?><pub-id pub-id-type="pmid">8041751</pub-id></mixed-citation></ref><ref id="ppat.1005853.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Hamann</surname><given-names>L</given-names></name>, <name><surname>Nickel</surname><given-names>R</given-names></name>, <name><surname>Tannich</surname><given-names>E</given-names></name>. <article-title>Transfection and continuous expression of heterologous genes in the protozoan parasite Entamoeba histolytica</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1995</year>; <volume>92</volume>(<issue>19</issue>):<fpage>8975</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 7568055?><pub-id pub-id-type="pmid">7568055</pub-id></mixed-citation></ref></ref-list></back></article>